medcode,clinicalevents,referralevents,testevents,immunisationevents,readcode,readterm,databasebuild,I,stopped,history,resolved,organ_bone
15422,2307,216,3,0,D20..00,Aplastic anaemia,Feb-09,,,,,
15658,85,10,0,0,D201.00,Acquired aplastic anaemia,Feb-09,,,,,
16108,95,4,0,0,D201000,Aplastic anaemia due to chronic disease,Feb-09,,,,,
21723,55,4,0,0,D201z00,Acquired aplastic anaemia NOS,Feb-09,,,,,
31275,29,6,1,0,D201611,Pancytopenia with malformation,Feb-09,,,,,
31491,4,0,0,0,D200211,Pancytopenia-dysmelia,Feb-09,,,,,
32715,11,0,0,0,D201111,Hypoplastic anaemia due to drug or chemical substance,Feb-09,,,,,
34754,48,0,0,0,D200100,Fanconi's familial refractory anaemia,Feb-09,,,,,
37320,70,9,0,0,D200000,Congenital hypoplastic anaemia,Feb-09,,,,,
37539,106,8,0,0,D2...00,Aplastic and other anaemias,Feb-09,,,,,
41142,21,1,0,0,D204.00,Idiopathic aplastic anaemia,Feb-09,,,,,
43166,10,0,0,0,D201100,Aplastic anaemia due to drugs,Feb-09,,,,,
44913,46,3,0,0,D200.15,Hypoplastic anaemia - familial,Feb-09,,,,,
57114,2,1,0,0,D201412,Hypoplastic anaemia due to toxic cause,Feb-09,,,,,
57859,5,0,0,0,D201200,Aplastic anaemia due to infection,Feb-09,,,,,
64625,6,0,0,0,D200111,Fanconi's hypoplastic anaemia,Feb-09,,,,,
66239,2,0,0,0,D201400,Aplastic anaemia due to toxic cause,Feb-09,,,,,
68087,42,1,0,0,D20z.00,Aplastic anaemia NOS,Feb-09,,,,,
69027,13,0,0,0,D200.00,Constitutional aplastic anaemia,Feb-09,,,,,
69061,3,0,0,0,D200011,Constitutional aplastic anaemia without malformation,Feb-09,,,,,
69379,2,0,0,0,D200y00,Other specified constitutional aplastic anaemia,Feb-09,,,,,
70128,1,0,0,0,D201311,Radiation aplastic anaemia,Feb-09,,,,,
83476,20,2,0,0,7Q09000,Hypoplastic haemolytic and renal anaemia drugs Band 1,Feb-09,,,,,
92968,4,0,0,0,7Q09100,Hypoplastic haemolytic and renal anaemia drugs Band 2,Feb-09,,,,,
102848,1,0,0,0,D200200,Constitutional aplastic anaemia with malformation,Aug-11,,,,,
105208,1,0,0,0,C300700,Adult Fanconi syndrome,Nov-12,,,,,
107206,5,1,0,0,C300600,Acquired Fanconi syndrome,Nov-13,,,,,
109608,3,0,0,0,C300A00,Congenital Fanconi syndrome,May-15,,,,,
112600,1,0,0,0,D201300,Aplastic anaemia due to radiation,Apr-18,,,,,
,,,,,,,,,,,,
21021,236,5,0,0,7K1Q.00,Graft of bone marrow,Feb-09,,,,,
1392,802,16,0,0,7K1Q.11,Bone marrow transplant,Feb-09,,,,,
15406,215,14,0,0,7K1Q100,Allograft of bone marrow NEC,Feb-09,,,,,
18628,763,7,0,0,7K1Q200,Transfusion of stem cells,Feb-09,,,,,
85492,17,0,0,0,7K1Q300,Allograft of bone marrow from sibling donor,Feb-09,,,,,
95840,6,0,0,0,7K1Q400,Allograft of bone marrow from matched unrelated donor,Feb-09,,,,,
100912,2,0,0,0,7K1Q500,Allograft of bone marrow from haploidentical donor,Nov-10,,,,,
98608,2,0,0,0,7K1Q600,Allograft of bone marrow from unmatched unrelated donor,Mar-10,,,,,
72436,3,0,0,0,7K1Qy00,Other specified graft of bone marrow,Feb-09,,,,,
70870,21,0,0,0,7K1Qz00,Graft of bone marrow NOS,Feb-09,,,,,
28232,86,1,0,0,7L14400,Peripheral blood stem cell graft,Feb-09,,,,,
54420,7,0,0,0,7L14411,Second stage peripheral stem cell infusion,Feb-09,,,,,
86063,406,0,0,0,7L14500,Autologous peripheral blood stem cell transplant,Feb-09,,,,,
110109,1,0,0,0,7L14600,Syngeneic peripheral blood stem cell transplant,Sep-15,,,,,
89920,115,0,0,0,7L14700,Allogeneic peripheral blood stem cell transplant,Feb-09,,,,,
63236,12,0,0,0,7L17311,First stage peripheral stem cell infusion,Feb-09,,,,,
52943,14,1,0,0,SP08200,Bone-marrow transplant rejection,Feb-09,,,,,
22728,102,1,0,0,SP08700,Acute graft-versus-host disease,Feb-09,,,,,
25695,127,2,0,0,SP08800,Chronic graft-versus-host disease,Feb-09,,,,,
93362,2,0,0,0,7K6i000,Allograft of cord blood to bone marrow,Feb-09,,,,,
100078,2,0,0,0,7K6i.00,Graft of cord blood to bone marrow,Jul-10,,,,,
34414,219,0,0,0,7K1Q000,Autograft of bone marrow,Feb-09,,,,,
320,78843,1390,0,0,7M37100,Radiotherapy NEC,Feb-09,,,,,
783,73710,1850,16,0,8BAD.00,CHEMOTHERAPY,,,,,,
1009,695,67,0,0,8HB6.00,Radiotherapy follow-up,Feb-09,,1,,,
1482,3427,93,3147,0,59...00,External radiotherapy,Feb-09,,,,,
5019,4263,57,1,0,8BAD000,CANCER CHEMOTHERAPY,,,,,,
5404,70,3,0,0,7M0P.00,Introduction removable radioactive material into organ NOC,Feb-09,,,,,
5527,1110,15,0,0,ZV58000,[V]Radiotherapy session,Feb-09,,,,,
9706,1988,21,4488,0,5154.00,Radiotherapy completed,Feb-09,,1,,,
10346,9858,30,0,0,9N0D.00,Seen in radiotherapy clinic,Feb-09,,,,,
10542,293,5,992,0,5A16.00,Radioactive drug therapy,Feb-09,,,,,
10776,132,10,95,0,5A...11,Radiotherapy - internal,Feb-09,,,,,
10932,1519,394,0,0,8H67.00,Referred for radiotherapy,Feb-09,,,,,
10950,1470,2,1,0,ZL93100,Seen by radiotherapist,Feb-09,,,,,
14887,11278,980,9,0,8BA5.00,ORAL CHEMOTHERAPY,,,,,,
15362,83,6,0,0,7E0C000,Introduction of radioactive substance into uterine cavity,Feb-09,,,,,
15386,6300,85,0,0,7L16100,INTRAVENOUS CHEMOTHERAPY,,,,,,
16662,37,3,0,0,ZV66100,[V]Convalescence after radiotherapy,Feb-09,,,,,
16771,463,1788,3575,0,59...11,X-ray therapy -external,Feb-09,,,,,
16935,356,3,417,0,515..00,Progress of radiotherapy,Feb-09,,,,,
18079,1362,150,0,0,8HB7.00,CHEMOTHERAPY FOLLOW-UP,,,1,,,
18675,525,1,0,0,8BAK.00,POST-OPERARTIVE CHEMOTHERAPY,,,,,,
18715,145,2,229,0,5AB..00,Stereotactic radiotherapy,Feb-09,,,,,
18832,595,0,0,0,8BAa.00,DATE CHEMOTHERAPY COMPLETED,,,1,,,
18904,200,6,0,0,ZV67100,[V]Radiotherapy follow-up,Feb-09,,1,,,
19467,148,0,0,0,8BAJ.00,PRE-OPERATIVE CHEMOTHERAPY,,,,,,
20282,12,0,0,0,7M0Py00,Introduction removable radioactive material to organ NOC OS,Feb-09,,,,,
20336,14,0,0,0,7272200,Radiotherapy to lesion of retina,Feb-09,,,,,
20381,74,2,0,0,ZV58100,[V]MAINTENANCE CHEMOTHERAPY,,,,,,
20443,160,2,0,0,ZV67200,[V]CHEMOTHERAPY FOLLOW-UP,,,1,,,
21318,756,0,0,0,8BA5.11,Oral cytotoxic drug therapy,Feb-09,,,,,
22472,123,6,565,0,59Z..00,External radiotherapy NOS,Feb-09,,,,,
22490,56,0,0,0,8BAL.00,COMBINED PRE-OPERATIVE CHEMOTHERAPY AND RADIOTHERAPY,,,,,,
23589,43,1,0,0,7M0Pz00,Introduction removable radioactive material to organ NOC NOS,Feb-09,,,,,
25479,40,0,0,0,ZV67800,[V]FOLLOW-UP EXAMIN AFTER CHEMOTHERAPY FOR MALIGN NEOPLASM,,,1,,,
25490,181,0,0,0,ZLD2400,Discharge by radiotherapist,Feb-09,,1,,,
26149,1388,2,0,0,8CV1.00,CHEMOTHERAPY STARTED,,,,,,
28071,290,0,0,0,7L10200,CONTINUOUS INFUSION OF CHEMOTHERAPY,,,,,,
28427,4,0,0,0,7D03400,Implantation of radioactive substance into vulva,Feb-09,,,,,
28712,189,0,0,0,8J01.00,Iodine seed radiotherapy,Feb-09,,,,,
28809,78,0,0,0,8BAM.00,COMBINED POST-OPERATIVE CHEMOTHERAPY AND RADIOTHERAPY,,,,,,
29285,319,18,454,0,5149.00,Radiotherapy-tumour palliation,Feb-09,,,,,
29301,86,5,38,0,514Z.00,Radiotherapy purpose - NOS,Feb-09,,,,,
29679,111,15,212,0,5146.00,Radiotherapy - post-op.control,Feb-09,,,,,
30264,289,7,0,0,7L19300,SUBCUTANEOUS CHEMOTHERAPY,,,,,,
30547,97,3,0,0,ZV67700,[V]Follow-up exam after radiotherapy for malignant neoplasm,Feb-09,,1,,,
30942,5092,161,1,0,9N1yC00,Seen in radiotherapy clinic,Feb-09,,,,,
31489,225,10,0,0,ZV58800,[V]CHEMOTHERAPY SESSION FOR NEOPLASM,,,,,,
31527,134,13,130,0,514..00,Purpose of radiotherapy,Feb-09,,,,,
31804,90,0,0,0,TB12100,"Radiotherapy procedure with complication, without blame",Feb-09,,,,,
32478,147,2,0,0,ZL13100,Under care of radiotherapist,Feb-09,,,,,
35597,31,0,11,0,5147.00,Radiotherapy for analgesia,Feb-09,,,,,
35609,11,0,0,0,ZV66200,[V]CONVALESCENCE AFTER CHEMOTHERAPY,,,1,,,
36225,10,0,4,0,5A4..11,Radium needles,Feb-09,,,,,
36810,21,0,31,0,5AC..00,Strontium 89 therapy,Feb-09,,,,,
36981,374,3,481,0,5155.00,Awaiting radiotherapy,Feb-09,,,,,
37123,4709,1,0,0,7L18200,INTRAMUSCULAR CHEMOTHERAPY,,,,,,
38466,480,4,916,0,5151.00,Radiotherapy started,Feb-09,,,,,
38662,101,4,0,0,7M0P000,Introduction of radioactive caesium into organ NOC,Feb-09,,,,,
38773,9,6,137,0,5A...00,Other nuclear therapy,Feb-09,,,,,
39951,37,1,36,0,5A9..00,Selectron therapy,Feb-09,,,,,
40070,34,0,0,0,7101100,Implantation of radioactive substance into pituitary gland,Feb-09,,,,,
40310,30,1,0,0,D400312,Neutropenia due to irradiation,Feb-09,,,,,
40490,161,17,0,0,7046200,INTRATHECAL CHEMOTHERAPY,,,,,,
41044,58,3,0,0,8J...00,Radiotherapy treatment groups,Feb-09,,,,,
42351,9,0,69,0,591..00,X-ray beam therapy,Feb-09,,,,,
42671,5,1,20,0,5A8..00,Other radiotherapy misc.,Feb-09,,,,,
43261,18,0,21,0,5144.00,Radiotherapy - pre-op. control,Feb-09,,,,,
44148,19,1,16,0,5914.11,Deep X-ray therapy,Feb-09,,,,,
44831,20,1,74,0,5153.00,Radiotherapy stopped,Feb-09,,1,,,
45087,175,67,0,0,8H3L.00,Non-urgent radiotherapy admisn,Feb-09,,,,,
45099,16,0,50,0,515Z.00,Radiotherapy progress NOS,Feb-09,,,,,
46028,225,0,0,0,8BAY.00,DATE CHEMOTHERAPY STOPPED,,,1,,,
46824,96,19,0,0,8H2G.00,Admit radiotherapy emergency,Feb-09,,,,,
48991,0,2,4,0,5136.00,X-ray metastasis control,Feb-09,,,,,
49760,1,0,0,0,U603318,[X] Adverse reaction to mitomycin,Feb-09,,,,,
50731,2,0,0,0,7H2C000,Introduction of radioactive substance into peritoneal cavity,Feb-09,,,,,
51781,67,5,0,0,ZVu3L00,[X]OTHER CHEMOTHERAPY,,,,,,
51787,7,0,5,0,5975.00,EXT.BEAM + CHEMOTHERAPY,,,,,,
51959,72,0,0,0,8BAI.00,AMBULATORY CHEMOTHERAPY,,,,,,
52108,2,1,0,0,8F83.00,Convalescence after radiother.,Feb-09,,1,,,
53180,12,0,17,0,5A46.00,Radioth.: temp. pelvic implant,Feb-09,,,,,
53477,10,0,0,0,ZV67811,[V]FOLLOW-UP EXAMINATION AFTER CHEMOTHERAPY FOR LEUKAEMIA,,,1,,,
54828,11,0,0,0,7D15400,Implantation of radioactive substance into vagina,Feb-09,,,,,
54919,14,0,101,0,5A8Z.00,Other radiotherapy NOS,Feb-09,,,,,
55261,0,1,2,0,5152.00,Radiotherapy changed,Feb-09,,,,,
55828,1,1,5,0,5145.00,Radiotherapy -intra-op.control,Feb-09,,,,,
55832,5,0,13,0,5143.00,Radioth. for lymphat.irradiat.,Feb-09,,,,,
55836,4,1,4,0,5148.00,Radiotherapy for inflammation,Feb-09,,,,,
57591,4,0,44,0,591Z.00,X-ray beam therapy NOS,Feb-09,,,,,
58036,3,0,0,0,7220100,Radiotherapy to lacrimal gland,Feb-09,,,,,
59684,185,0,0,0,7M0c.00,Radiotherapy procedures,Feb-09,,,,,
59796,3,2,49,0,5914.00,Deep X-ray therapy 150-400 Kv,Feb-09,,,,,
59890,0,0,1,0,5913.00,Half deep therapy 60-150 Kv,Feb-09,,,,,
60076,2,0,2,0,5141.00,Radioth.for immunosuppression,Feb-09,,,,,
60091,4,0,29,0,5912.00,Superfic.X-ray therapy 10-60Kv,Feb-09,,,,,
60674,11,0,0,0,7052200,Radiotherapy to lesion of peripheral nerve,Feb-09,,,,,
60682,11,0,0,0,ZV6B100,[V]FOLLOW-UP EXAM AFTER CHEMOTHERAPY FOR OTHER CONDITIONS,,,1,,,
61955,6,0,8,0,5AA..00,Iridium wire therapy,Feb-09,,,,,
62202,20,0,0,0,8J00.00,High dose brachytherapy,Feb-09,,,,,
62864,0,0,1,0,5A73.00,Radio-chemo.: oral route,Feb-09,,,,,
62951,3,0,28,0,5A15.00,Bone tumour/metast.irradiat.,Feb-09,,,,,
64143,1,0,4,0,597Z.00,Combined radiotherapy NOS,Feb-09,,,,,
64801,1,0,2,0,5A3..00,Intern.radioth-permanent seeds,Feb-09,,,,,
64997,74,1,0,0,7L1d.00,DELIVERY OF CHEMOTHERAPY FOR NEOPLASM,,,,,,
65739,1,0,0,0,5A53.00,Preload radioth.- nose,Feb-09,,,,,
67248,3,0,13,0,5A12.00,Thyroid tumour/metast irradiat,Feb-09,,,,,
68344,4,0,0,0,7244400,Radiotherapy to lesion of cornea,Feb-09,,,,,
68423,210,0,0,0,7L1Z.00,Radiotherapy delivery,Feb-09,,,,,
69165,0,0,2,0,594..00,Heavy particle therapy,Feb-09,,,,,
69387,0,0,1,0,5974.00,EXT.BEAM-SURGERY+CHEMOTHERAPY,,,,,,
69877,0,0,3,0,5A3Z.00,Radioth.: permanent seeds NOS,Feb-09,,,,,
69979,4,1,18,0,5AZ..00,Other nuclear therapy NOS,Feb-09,,,,,
70128,1,0,0,0,D201311,Radiation aplastic anaemia,Feb-09,,,,,
70246,1,0,29,0,5A1..00,Internal metabolic radiotherap,Feb-09,,,,,
70290,0,0,2,0,5A7..00,RADIOMIMETIC CHEMOTHERAPY,,,,,,
70386,3,0,0,0,TA32.00,Overdose of radiation in therapy,Feb-09,,,,,
70445,4,0,0,0,7M0cy00,Other specified radiotherapy procedures,Feb-09,,,,,
70478,2,0,23,0,5A4..00,Radioth.: temporary implant,Feb-09,,,,,
70549,7,0,0,0,5142.00,Radioth. for haemopo. irradiat,Feb-09,,,,,
71008,160,0,0,0,7809400,Percutaneous radiofrequency ablation of lesion of liver,Feb-09,,,,,
71098,0,0,19,0,592Z.00,High-energy beam therapy NOS,Feb-09,,,,,
71598,1,0,1,0,5A45.00,Radioth.: temp. abdom. implant,Feb-09,,,,,
71599,0,0,2,0,5A1Z.00,Internal metabolic radioth.NOS,Feb-09,,,,,
71837,7,1,0,0,U603300,[X]OTHER ANTINEOPLAST DRUGS CAUS ADVERSE EFF IN THERAP USE,,,,,,
71926,0,0,4,0,5134.00,X-ray # reduction control,Feb-09,,,,,
72850,0,0,4,0,5971.00,Extern.beam+intern.radiotherap,Feb-09,,,,,
72978,1,0,21,0,597..00,Combined radiotherapy,Feb-09,,,,,
73171,0,0,6,0,5A64.00,Afterload radioth.-fem.genital,Feb-09,,,,,
73172,0,0,8,0,5A7Z.00,RADIO-CHEMOTHERAPY NOS,,,,,,
73173,4,0,4,0,5A13.00,Bone marrow suppres.-irradiat.,Feb-09,,,,,
73300,0,0,1,0,5922.00,Betatron photon therapy,Feb-09,,,,,
73462,0,0,4,0,5917.00,Intracavitary X-ray therapy,Feb-09,,,,,
73692,2,0,5,0,5A4Z.00,Radioth.:temporary implant NOS,Feb-09,,,,,
85984,0,0,22,0,5941.00,Proton therapy,Feb-09,,,,,
87860,18,0,0,0,7M0P300,Intro radioactive substance org interstit brachytherapy NOC,Feb-09,,,,,
88367,94,0,0,0,7B0A800,Percutaneous radiofrequency ablation of lesion of kidney,Feb-09,,,,,
88762,0,0,4,0,5135.00,Radiological tumour control,Feb-09,,,,,
88889,23,0,0,0,7M0Q300,Radioactive seed implantation NOC,Feb-09,,,,,
89452,3,0,0,0,7L1b.00,PROCUREMENT DRUGS FOR CHEMOTHERAPY FOR NEOPLASM IN BANDS 1-5,,,,,,
90743,21,0,0,0,7L1e.00,DELIVERY OF ORAL CHEMOTHERAPY FOR NEOPLASM,,,,,,
91433,89,0,0,0,7B3CB00,Radioactive seed implantation into prostate,Feb-09,,,,,
91694,59,0,0,0,7L1Z300,Delivery of a fraction of external beam radiotherapy NEC,Feb-09,,,,,
91778,1,0,0,0,7L1d000,Del comp chemo neo inc prolong infusion treat first attend,Feb-09,,,,,
91891,29,0,0,0,7L1Zz00,Radiotherapy delivery NOS,Feb-09,,,,,
91918,12,0,0,0,7272700,External beam radiotherapy to lesion of retina,Feb-09,,,,,
92174,79,1,0,0,7454400,Percutaneous radiofrequency ablation of lesion of lung,Feb-09,,,,,
92956,8,0,0,0,7L1Z011,Delivery of a fraction of total body irradiation,Feb-09,,,,,
92999,0,0,1,0,5A27.00,Radioth.: infuse organ cavity,Feb-09,,,,,
93607,0,0,1,0,5A81.00,Give radiosensitising drug,Feb-09,,,,,
93669,13,0,0,0,7L1Y.00,Radiotherapy preparation,Feb-09,,,,,
94305,0,0,9,0,596..00,Short dis.+contact radiotherap,Feb-09,,,,,
94306,1,0,2,0,593..00,Fast-electron therapy,Feb-09,,,,,
94431,1,0,0,0,7L1ez00,DELIVERY OF ORAL CHEMOTHERAPY FOR NEOPLASM NOS,,,,,,
94478,0,0,7,0,5A42.00,Radioth:temp.head/neck implant,Feb-09,,,,,
94479,0,0,2,0,5973.00,Ext.beam-surg.+post-op.radioth,Feb-09,,,,,
94617,0,0,1,0,5A62.00,Afterload radioth.- upper GIT,Feb-09,,,,,
94760,1,0,0,0,U603316,[X] Adverse reaction to chlorambucil,Feb-09,,,,,
94764,3,0,0,0,7L1Y000,Preparation for total body irradiation,Feb-09,,,,,
95009,11,0,0,0,7L1Z100,Delivery of a fraction of intracavitary radiotherapy,Feb-09,,,,,
95066,1,1,4,0,5961.00,Radium contact therapy,Feb-09,,,,,
95098,0,0,1,0,5A33.00,Radioth.: seeds into cavity,Feb-09,,,,,
95126,8,0,0,0,7L1Zy00,Other specified radiotherapy delivery,Feb-09,,,,,
95424,2,0,0,0,7L1dz00,DELIVERY OF CHEMOTHERAPY FOR NEOPLASM NOS,,,,,,
95693,1,0,0,0,7L1Xy00,Other specified radiotherapy volume definition,Feb-09,,,,,
95851,1,0,0,0,U603311,[X] ADVERSE REACTION TO ANTINEOPLASTIC ANTIBIOTICS,,,,,,
95890,0,0,10,0,5962.00,Beta source contact therapy,Feb-09,,,,,
96310,1,0,0,0,7L1dy00,OTHER SPECIFIED DELIVERY OF CHEMOTHERAPY FOR NEOPLASM,,,,,,
96446,2,0,0,0,U613200,[X]Overdose of radiation given during therapy,Apr-09,,,,,
96458,9,0,0,0,7L1Z000,Delivery of a fraction of total body irradiation (TBI),Apr-09,,,,,
96467,0,0,2,0,5942.00,Deuteron therapy,Apr-09,,,,,
96535,3,0,0,0,7B3BC00,Endoscopic radiofrequency ablation of lesion of prostate,Apr-09,,,,,
97097,0,1,1,0,5131.00,Radiological pre-op. control,Aug-09,,,,,
97106,0,0,2,0,5A28.00,Radioth.: infiltrate tissue,Aug-09,,,,,
97154,0,0,7,0,5137.00,X-ray radiotherapy control,Aug-09,,,,,
97253,41,1,0,0,7K1V700,Percutaneous radiofrequency ablation of lesion of bone,Aug-09,,,,,
97412,54,0,0,0,7M0P400,Intro radioactive substance into organ for brachytherapy NOC,Aug-09,,,,,
98358,1,0,0,0,7L1h000,Preparation for intensity modulated radiation therapy,Jan-10,,,,,
98625,2,0,0,0,U603100,[X]ANTINEOPLAST ANTIMETABS CAUS ADVERSE EFF IN THERAP USE,,,,,,
98750,4,0,0,0,Z9KG500,Brachytherapy monitoring,Mar-10,,,,,
98826,1,0,5,0,5A58.00,Preload radioth-female genital,Mar-10,,,,,
98828,0,0,8,0,592..00,High-energy beam therapy,Mar-10,,,,,
98829,0,0,2,0,5921.00,Linear-accelerator photon ther,Mar-10,,,,,
98830,0,0,3,0,593Z.00,Fast-electron therapy NOS,Mar-10,,,,,
98882,0,0,1,0,5A74.00,Radio-chemo.: I-V route,Apr-10,,,,,
98902,7,0,0,0,7M0c500,Superficial or orthovoltage treatment for radiotherapy,Apr-10,,,,,
98940,8,0,0,0,7L1i.00,Preparation for brachytherapy,Apr-10,,,,,
99327,0,0,1,0,5963.00,Mould technique gamma/beta,May-10,,,,,
99469,0,0,1,0,56B5.00,Image: field control:radiother,May-10,,,,,
100382,0,0,1,0,5A21.00,Radioth.: infuse - skull/brain,Aug-10,,,,,
100390,2,0,0,0,7M0P500,Intro non-remov radioact subst into organ for brachyther NOC,Aug-10,,,,,
100396,5,0,0,0,7L1Z500,Delivery of a fraction of intraluminal brachytherapy,Aug-10,,,,,
100724,0,0,1,0,5A2Z.00,Intern. unsealed radioth. NOS,Sep-10,,,,,
100725,0,0,3,0,5A26.00,Radioth:infuse-urinary bladder,Sep-10,,,,,
100758,0,0,2,0,5953.00,Comb.tele+int.dist.curietherap,Nov-10,,,,,
100832,0,0,2,0,5133.00,Radiological post-op. control,Nov-10,,,,,
100901,1,0,0,0,7M0c400,Megavoltage treatment for simple radiotherapy,Nov-10,,,,,
100942,1,0,0,0,U60331B,[X] Adverse reaction to estramustine phosphate,Nov-10,,,,,
101203,3,0,0,0,Z1Q1.11,Administering radionuclide,Dec-10,,,,,
101391,7,0,0,0,7809300,Selective internal radiotherapy microspheres lesion of liver,Jan-11,,,,,
101436,1,0,0,0,U603314,[X] Adverse reaction to bleomycin,Jan-11,,,,,
101693,153,0,0,0,8CRC.00,Cancer chemotherapy management plan,Feb-11,,,,,
102671,0,0,1,0,5A59.00,Preload radioth-urinary system,Jul-11,,,,,
102672,0,0,1,0,5A14.00,Polycythaemia irradiation,Jul-11,,,,,
102823,1,0,0,0,782M600,Percutaneous brachytherapy of lesion of bile duct,Aug-11,,,,,
103302,1,1,0,0,U603200,[X]Antineoplast natural prod caus adverse eff in therap use,Nov-11,,,,,
103372,1,0,0,0,5A2..00,Intern.radioth-unsealed source,Dec-11,,,,,
103413,1,0,0,0,7L1i100,Preparation for intracavitary brachytherapy,Dec-11,,,,,
103525,1,0,0,0,7L1Z200,Delivery of a fraction of interstitial radiotherapy,Jan-12,,,,,
103600,1,0,0,0,U603118,[X] Adverse reaction to carboplatin,Jan-12,,,,,
103872,2,0,0,0,7M0l.00,Support for preparation for radiotherapy,Mar-12,,,,,
103957,5,0,0,0,7B3CA00,Transurethral radiofrequency needle ablation of prostate,Apr-12,,,,,
104000,1,0,0,0,7L1h400,Prep for simple radioth with imaging and simple calculation,May-12,,,,,
104099,1,0,0,0,7M0c300,Megavoltage treatment for complex radiotherapy,May-12,,,,,
104142,83,0,0,0,8BAl.00,Neoadjuvant chemotherapy,May-12,,,,,
105128,0,0,1,0,596Z.00,Short dist/contact radioth NOS,Nov-12,,,,,
105129,0,0,1,0,5A57.00,Preload radioth.- resp.organs,Nov-12,,,,,
105323,1,0,0,0,7M0c000,Delivery fraction complex radiotherapy megavoltage machine,Dec-12,,,,,
105336,10,0,0,0,7L1d400,Electrochemotherapy,Dec-12,,,,,
105610,1,0,0,0,7M0ly00,Other specified support for preparation for radiotherapy,Jan-13,,,,,
106149,0,0,1,0,5933.00,Positron therapy,May-13,,,,,
106334,1,1,0,0,5A22.00,Radioth.: infuse - head/neck,Jun-13,,,,,
107069,1,0,0,0,7L1Yz00,Radiotherapy preparation NOS,Oct-13,,,,,
107130,0,0,2,0,5A77.00,Radio-chem.: into cavity,Oct-13,,,,,
107133,0,0,187,0,595..00,Gamma-ray+int.dist.curietherap,Oct-13,,,,,
107175,0,0,1,0,5A51.00,Preload radioth.- orbit,Oct-13,,,,,
107418,0,0,1,0,5A17.00,Combined internal radiotherapy,Dec-13,,,,,
107525,1,0,0,0,7L1iz00,Preparation for brachytherapy NOS,Dec-13,,,,,
107734,1,0,0,0,7L1d200,Deliver simple parenteral chemother neoplas first attendance,Feb-14,,,,,
107914,1,0,0,0,U60331D,[X] Adverse reaction to antineoplastic antibiotics NOS,Apr-14,,,,,
108138,902,1,0,0,7L2..00,Radiotherapy,Jun-14,,,,,
108140,1,0,0,0,7L1hz00,Preparation for external beam radiotherapy NOS,Jun-14,,,,,
108202,1,0,0,0,7M0c200,Delivery fraction radiotherapy superficial orthovoltage mach,Jun-14,,,,,
108561,13,0,0,0,7Q0J.00,Other chemotherapy drugs,Aug-14,,,,,
109592,0,0,2,0,5932.00,Betatron electron therapy,Apr-15,,,,,
110074,3,0,0,0,7M0p000,High dose rate brachytherapy,Sep-15,,,,,
110894,0,1,0,0,SL07.00,Antineoplastic antibiotic poisoning,Jun-16,,,,,
111213,2,0,0,0,7Q0J200,Other specified other chemotherapy drugs,Aug-16,,,,,
111244,1,0,0,0,7L1X000,Vol def radioth imag intensity-modul radia ther (IMRT) dosim,Aug-16,,,,,
111583,2,0,0,0,D400300,Agranulocytosis due to irradiation,Dec-16,,,,,
111949,1,0,0,0,7L1h100,Preparation for total body irradiation,Sep-17,,,,,
2835,,,,,43C3.11,HIV positive,,,,,,
8281,,,,,A789A00,HIV disease resulting in wasting syndrome,,,,,,
9130,,,,,A788.11,Human immunodeficiency virus infection,,,,,,
23763,,,,,65QA.00,AIDS carrier,,,,,,
23770,,,,,A788.00,Acquired immune deficiency syndrome,,,,,,
23951,,,,,A789200,HIV disease resulting in candidiasis,,,,,,
24872,,,,,ZV01A00,[V]Asymptomatic human immunodeficency virus infection status,,,,,,
27053,19,0,284,0,4J34.00,HIV viral load,Jan-09,,,,,
27641,,,,,A789300,HIV disease resulting in Pneumocystis carinii pneumonia,,,,,,
27853,,,,,A789500,HIV disease resulting in Kaposi's sarcoma,,,,,,
33943,46,1,0,0,65VE.00,Notification of AIDS,Jan-09,,,,,
36294,,,,,A788z00,Acquired human immunodeficiency virus infection syndrome NOS,,,,,,
37006,,,,,A789000,HIV disease resulting in mycobacterial infection,,,,,,
41185,,,,,Eu02400,[X]Dementia in human immunodef virus [HIV] disease,,,,,,
43537,0,0,42,0,43j7.00,HIV 1 nucleic acid detection,Jan-09,,,,,
44288,,,,,R109.00,[D]Laboratory evidence of human immunodeficiency virus [HIV],,,,,,
44303,,,,,A789.00,Human immunodef virus resulting in other disease,,,,,,
44617,,,,,A789600,HIV disease resulting in Burkitt's lymphoma,,,,,,
47632,,,,,A788U00,"HIV disease result/haematological+immunologic abnorms,NEC",,,,,,
50076,,,,,A789400,HIV disease resulting in multiple infections,,,,,,
51708,,,,,A789X00,"HIV dis reslt/oth mal neopl/lymph,h'matopoetc+reltd tissu",,,,,,
53636,,,,,A788400,Human immunodeficiency virus with neurological disease,,,,,,
58857,,,,,A788000,Acute human immunodeficiency virus infection,,,,,,
58859,,,,,A788100,Asymptomatic human immunodeficiency virus infection,,,,,,
62854,,,,,AyuC.00,[X]Human immunodeficiency virus disease,,,,,,
62891,,,,,A788y00,Human immunodeficiency virus with other clinical findings,,,,,,
65117,,,,,A789900,HIV disease resulting in lymphoid interstitial pneumonitis,,,,,,
66367,,,,,A789700,HIV dis resulting oth types of non-Hodgkin's lymphoma,,,,,,
66368,,,,,A789100,HIV disease resulting in cytomegaloviral disease,,,,,,
67575,,,,,A788W00,HIV disease resulting in unspecified malignant neoplasm,,,,,,
69766,,,,,A788200,HIV infection with persistent generalised lymphadenopathy,,,,,,
69767,,,,,AyuC600,[X]HIV disease resulting in other non-Hodgkin's lymphoma,,,,,,
70528,,,,,A788500,Human immunodeficiency virus with secondary infection,,,,,,
70869,,,,,A788300,Human immunodeficiency virus with constitutional disease,,,,,,
71450,,,,,A788X00,HIV disease resulting/unspcf infectious+parasitic disease,,,,,,
93642,0,0,11,0,43w3.00,Human immunodeficiency virus RNA/DNA ratio,Jan-09,,,,,
96751,,,,,AyuCB00,"[X]HIV disease result/haematological+immunologic abnorms,NEC",,,,,,
96902,0,0,1,0,4J3F.00,Human immunodeficiency virus viral load by log rank,Jan-09,,,,,
100769,1,0,0,0,AyuCD00,[X]Unspecified human immunodeficiency virus [HIV] disease,Jan-10,,,,,
101191,1,0,0,0,66j0.00,Human immunodeficiency virus annual review,Jan-10,,,,,
101836,0,0,0,0,A788600,Human immunodeficiency virus with secondary cancers,Mar-11,,,,,
102117,1,0,0,0,AyuC300,[X]HIV disease resulting in multiple infections,Apr-11,,,,,
102252,1,0,0,0,AyuCC00,[X]HIV disease resulting in other specified conditions,May-11,,,,,
104134,1,0,0,0,AyuC400,[X]HIV disease resulting/other infectious+parasitic diseases,May-12,,,,,
104466,3,0,0,0,L179.00,HIV disease complicating pregnancy childbirth puerperium,Jul-12,,,,,
104717,1,0,0,0,A789311,HIV disease resulting in Pneumocystis jirovecii pneumonia,Aug-12,,,,,
105040,2,0,0,0,9kl..00,HIV pos gen health check serv declind - enhanc service admin,Oct-12,,,,,
105324,1,0,0,0,A789800,HIV disease resulting in multiple malignant neoplasms,Dec-12,,,,,
107807,1,0,0,0,AyuC100,[X]HIV disease resulting in other viral infections,Mar-14,,,,,
108054,4,1,0,0,A789511,HIV disease resulting in Kaposi sarcoma,May-14,,,,,
109513,0,0,2,0,4J3N.00,Human immunodeficiency virus drug resistance test,Apr-15,,,,,
110374,0,0,3,0,4J3P.00,Human immunodeficiency virus type 1 subtype identification,Dec-15,,,,,
111971,1,0,0,0,9kl..11,HIV positive general health check service declined,Sep-17,,,,,
111972,1,0,0,0,9mN0000,HIV infection monitoring first telephone invitation,Sep-17,,,,,
111973,1,0,0,0,9mN0100,HIV infection monitoring second telephone invitation,Sep-17,,,,,
111974,1,0,0,0,9mN0200,HIV infection monitoring third telephone invitation,Sep-17,,,,,
111979,1,0,0,0,A788V00,HIV disease resulting in multiple diseases CE,Sep-17,,,,,
111980,1,0,0,0,A789611,HIV disease resulting in Burkitt lymphoma,Sep-17,,,,,
111981,1,0,0,0,A789711,HIV disease resulting in other types of non-Hodgkin lymphoma,Sep-17,,,,,
112030,1,0,0,0,AyuC000,[X]HIV disease resulting in other bacterial infections,Sep-17,,,,,
112031,1,0,0,0,AyuC200,[X]HIV disease resulting in other mycoses,Sep-17,,,,,
112032,1,0,0,0,AyuC500,[X]HIV disease resulting/unspcf infectious+parasitic disease,Sep-17,,,,,
112033,1,0,0,0,AyuC611,[X]HIV disease resulting in other non-Hodgkin lymphoma,Sep-17,,,,,
112034,1,0,0,0,AyuC700,"[X]HIV dis reslt/oth mal neopl/lymph,h'matopoetc+reltd tissu",Sep-17,,,,,
112035,1,0,0,0,AyuC800,[X]HIV disease resulting in other malignant neoplasms,Sep-17,,,,,
112036,1,0,0,0,AyuC900,[X]HIV disease resulting in unspecified malignant neoplasm,Sep-17,,,,,
112037,1,0,0,0,AyuCA00,[X]HIV disease resulting in multiple diseases CE,Sep-17,,,,,
27439,346,23,0,0,BBTA.00,[M]Kaposi's sarcoma,Feb-09,,,,,
27931,77,4,0,0,B33z000,Kaposi's sarcoma of skin,Feb-09,,,,,
49525,57,1,0,0,B59zX00,"Kaposi's sarcoma, unspecified",Feb-09,,,,,
93665,6,0,0,0,Byu5300,"[X]Kaposi's sarcoma, unspecified",Feb-09,,,,,
104128,6,0,0,0,B31z000,Kaposi's sarcoma of soft tissue,May-12,,,,,
50290,5,0,0,0,B6z0.00,Kaposi's sarcoma of lymph nodes,Feb-09,,,,,
98361,3,0,0,0,Byu5B00,[X]Kaposi's sarcoma of other sites,Jan-10,,,,,
65466,2,0,0,0,B592X00,Kaposi's sarcoma of multiple organs,Feb-09,,,,,
37549,9,0,0,0,B05z000,Kaposi's sarcoma of palate,Feb-09,,,,,
1481,45,1,0,0,B600.00,Reticulosarcoma,Feb-09,,,,,
1483,11099,639,2,0,BBg1.11,[M]Lymphoma NOS,Feb-09,,,,,
2462,8764,410,13,0,B61..00,Hodgkin's disease,Feb-09,,,,,
3371,2708,113,0,0,BBg2.11,[M]Non Hodgkins lymphoma,Feb-09,,,,,
3604,11303,474,0,0,B627.00,Non - Hodgkin's lymphoma,Feb-09,,,,,
3672,5387,285,9,0,BBn0.12,[M]MYELOMA NOS,,,,,,
3710,366,31,0,0,BBB1.00,[M]Adenolymphoma,Feb-09,,,,,
4072,467,43,0,0,B680.00,Acute leukaemia NOS,Feb-09,,,,,
4222,2038,120,0,0,B64..11,Lymphatic leukaemia,Feb-09,,,,,
4250,3021,374,0,0,B68z.00,Leukaemia NOS,Feb-09,,,,,
4251,2143,109,0,0,B640.00,Acute lymphoid leukaemia,Feb-09,,,,,
4413,4832,174,0,0,B650.00,Acute myeloid leukaemia,Feb-09,,,,,
4561,7367,280,1,0,B937W11,Myelodysplasia,Feb-09,,,,,
4637,605,13,0,0,BBr..00,[M]Leukaemias,Feb-09,,,,,
4870,210,15,1,0,B625.11,"HISTIOCYTOSIS X (ACUTE, PROGRESSIVE)",,,,,,
4944,10335,601,3,0,B630.00,MULTIPLE MYELOMA,,,,,,
5137,295,81,1,0,B624.11,Leukaemic reticuloendotheliosis,Feb-09,,,,,
5179,225,11,1,0,B620.00,Nodular lymphoma (Brill - Symmers disease),Feb-09,,,,,
5572,2835,117,1,0,D41y100,Myelofibrosis,Feb-09,,,,,
5915,480,12,0,0,BBrA400,[M]Hairy cell leukaemia,Feb-09,,,,,
6115,3695,142,0,0,B6y0.00,Myeloproliferative disorder,Feb-09,,,,,
6316,182,4,0,0,BBr0100,[M]Acute leukaemia NOS,Feb-09,,,,,
7176,2110,104,0,0,B65..00,Myeloid leukaemia,Feb-09,,,,,
7799,2363,46,0,0,BBv..00,[M]Myelodysplastic syndrome,Feb-09,,,,,
7940,282,5,0,0,ByuDF11,[X]Non-Hodgkin's lymphoma NOS,Feb-09,,,,,
8625,12699,1069,4,0,B641.00,Chronic lymphoid leukaemia,Feb-09,,,,,
8649,299,9,0,0,ByuDF00,"[X]Non-Hodgkin's lymphoma, unspecified type",Feb-09,,,,,
9172,804,24,0,0,BBmK.00,[M]WALDENSTROM'S MACROGLOBULINAEMIA,,,,,,
9673,580,40,1,0,BBs5.00,[M]Chronic lymphoproliferative disease,Feb-09,,,,,
10411,637,26,1,0,C333000,WALDENSTROM'S MACROGLOBULINAEMIA,,,,,,
10726,2582,151,0,0,B651.00,Chronic myeloid leukaemia,Feb-09,,,,,
12006,1900,102,0,0,B621.00,Mycosis fungoides,Feb-09,,,,,
12146,16,4,0,0,BBr2000,[M]Lymphoid leukaemia NOS,Feb-09,,,,,
12323,811,2,0,0,B6...00,MALIGNANT NEOPLASM OF LYMPHATIC AND HAEMOPOIETIC TISSUE,,,,,,
12335,5982,443,2,0,B62y.00,Malignant lymphoma NOS,Feb-09,,,,,
12464,96,9,0,0,B62x200,Peripheral T-cell lymphoma,Feb-09,,,,,
15027,715,43,0,0,B62yz00,Malignant lymphoma NOS,Feb-09,,,,,
15036,46,2,0,0,B626.00,MALIGNANT MAST CELL TUMOURS,,,,,,
15211,335,20,0,0,B630.12,MYELOMATOSIS,,,,,,
15504,136,3,0,0,B62y800,Malignant lymphoma NOS of lymph nodes of multiple sites,Feb-09,,,,,
16416,348,53,1,0,B681.00,Chronic leukaemia NOS,Feb-09,,,,,
16460,418,30,0,0,BBg2.00,"[M]Malignant lymphoma, non Hodgkin's type",Feb-09,,,,,
16774,307,6,0,0,BBmD.00,[M] Cutaneous lymphoma,Feb-09,,,,,
17056,989,37,0,0,B6y0.11,Myeloproliferative disease,Feb-09,,,,,
17177,620,36,0,0,1429,H/O: * leukaemia,Feb-09,,,1,,
17178,390,10,0,0,BBg..00,"[M]Lymphomas, NOS or diffuse",Feb-09,,,,,
17182,1117,6,0,0,B627C11,Follicular lymphoma NOS,Feb-09,,,,,
17460,67,2,0,0,B627700,Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma,Feb-09,,,,,
17887,594,8,0,0,B62x.00,Malignant lymphoma otherwise specified,Feb-09,,,,,
18383,424,6,0,0,BBmH.00,[M] Large cell lymphoma,Feb-09,,,,,
18744,356,4,0,0,BBn0.11,[M]MULTIPLE MYELOMA,,,,,,
19140,3,0,0,0,B614800,Hodgkin's nodular sclerosis of lymph nodes of multiple sites,Feb-09,,,,,
19372,1069,104,0,0,B64..00,Lymphoid leukaemia,Feb-09,,,,,
19974,39,5,0,0,B660.00,Acute monocytic leukaemia,Feb-09,,,,,
20437,295,8,0,0,BBk..00,"[M]Lymphomas, nodular or follicular",Feb-09,,,,,
20440,177,9,0,0,B69..00,Myelomonocytic leukaemia,Feb-09,,,,,
20635,25,1,0,0,BBr2011,[M]Lymphatic leukaemia,Feb-09,,,,,
20710,588,20,0,0,BBj..00,[M]Hodgkin's disease,Feb-09,,,,,
21329,408,4,0,0,B630200,PLASMACYTOMA NOS,,,,,,
21402,274,6,0,0,B602.00,Burkitt's lymphoma,Feb-09,,,,,
21463,201,1,0,0,BBgC.11,[M]Lymphocytic lymphoma NOS,Feb-09,,,,,
21549,490,12,0,0,B627C00,Follicular non-Hodgkin's lymphoma,Feb-09,,,,,
22050,358,6,0,0,B691.00,Chronic myelomonocytic leukaemia,Feb-09,,,,,
22071,8,0,0,0,BBr0111,[M]Blast cell leukaemia,Feb-09,,,,,
22158,86,1,0,0,B630000,"Malignant plasma cell neoplasm, extramedullary plasmacytoma",Feb-09,,,,,
23711,85,5,0,0,BBg1000,"[M]Malignant lymphoma, diffuse NOS",Feb-09,,,,,
25191,419,28,0,0,B68..00,Leukaemia of unspecified cell type,Feb-09,,,,,
26135,7,0,0,0,BBm6.00,[M] ALPHA HEAVY CHAIN DISEASE,,,,,,
27330,45,7,0,0,B624.00,Leukaemic reticuloendotheliosis,Feb-09,,,,,
27340,5,0,0,0,B670.11,Di Guglielmo's disease,Feb-09,,,,,
27416,172,8,0,0,B601.00,Lymphosarcoma,Feb-09,,,,,
27458,101,17,0,0,B661.00,Chronic monocytic leukaemia,Feb-09,,,,,
27520,51,1,0,0,B651z00,Chronic myeloid leukaemia NOS,Feb-09,,,,,
27664,181,2,0,0,B65y100,Acute promyelocytic leukaemia,Feb-09,,,,,
27790,664,55,0,0,B641.11,Chronic lymphatic leukaemia,Feb-09,,,,,
27965,19,1,0,0,BBv2.00,[M]AngiocentricT-cell lymphoma,Feb-09,,,,,
28276,226,13,0,0,B675.00,ACUTE MYELOFIBROSIS,,,,,,
28639,95,1,0,0,B627000,Follicular non-Hodgkin's small cleaved cell lymphoma,Feb-09,,,,,
29178,372,1,0,0,B614.00,"Hodgkin's disease, nodular sclerosis",Feb-09,,,,,
29335,80,2,0,0,BBr2700,[M]Adult T-cell leukaemia/lymphoma,Feb-09,,,,,
29876,4,0,0,0,B613z00,"Hodgkin's, lymphocytic-histiocytic predominance NOS",Feb-09,,,,,
30139,42,0,0,0,BBs..00,[M]Misc myeloproliferative and lymphoproliferative disorders,Feb-09,,,,,
30632,33,1,0,0,B67z.00,Other specified leukaemia NOS,Feb-09,,,,,
30646,14,0,0,0,B6y..00,MALIGNANT NEOPLASM LYMPHATIC OR HAEMATOPOIETIC TISSUE OS,,,,,,
31324,36,1,0,0,B626800,MAST CELL MALIGNANCY OF LYMPH NODES OF MULTIPLE SITES,,,,,,
31492,264,3,0,0,BBm9.00,[M] Monocytoid B-cell lymphoma,Feb-09,,,,,
31537,8,0,0,0,BBj1100,"[M]Hodgkin,s disease, lymphocytic predominance, nodular",Feb-09,,,,,
31576,58,1,0,0,B627B00,Other types of follicular non-Hodgkin's lymphoma,Feb-09,,,,,
31586,88,3,0,0,B64y100,Prolymphocytic leukaemia,Feb-09,,,,,
31671,285,15,0,0,BBn0.00,[M]PLASMA CELL MYELOMA,,,,,,
31701,150,8,0,0,B651.11,Chronic granulocytic leukaemia,Feb-09,,,,,
31726,5,0,0,0,BBgM.00,"[M]Malignant lymphoma, small cleaved cell, diffuse",Feb-09,,,,,
31741,1,0,0,0,BBj6200,"[M]Hodgkin,s disease, nodular sclerosis, lymphocytic deplet",Apr-10,,,,,
31749,15,0,0,0,BBv0.00,[M]Monocytoid B-cell lymphoma,Feb-09,,,,,
31750,87,3,0,0,BBr0300,[M]Chronic leukaemia NOS,Feb-09,,,,,
31794,474,1,0,0,B627W00,Unspecified B-cell non-Hodgkin's lymphoma,Feb-09,,,,,
32240,5,0,7,0,4M22.00,Lymphoma stage III,Feb-09,,,,,
33333,101,1,0,0,B62..00,OTHER MALIGNANT NEOPLASM OF LYMPHOID AND HISTIOCYTIC TISSUE,,,,,,
33344,25,0,0,0,B65z.00,Myeloid leukaemia NOS,Feb-09,,,,,
33869,91,0,0,0,BBgR.00,"[M]Malignant lymphoma, large cell, diffuse NOS",Feb-09,,,,,
34089,5,0,0,0,B62y400,Malignant lymphoma NOS of lymph nodes of axilla and arm,Feb-09,,,,,
34352,89,15,0,0,BBgG.12,[M]Lymphoblastic lymphoma NOS,Feb-09,,,,,
34692,22,3,0,0,B68y.00,Other leukaemia of unspecified cell type,Feb-09,,,,,
34926,45,0,0,0,B625.00,LETTERER-SIWE DISEASE,,,,,,
35014,52,6,0,0,B622.00,Sezary's disease,Feb-09,,,,,
35697,39,0,0,0,BBr6.00,[M]Myeloid leukaemias,Feb-09,,,,,
35875,35,5,0,0,B66..00,Monocytic leukaemia,Feb-09,,,,,
36114,416,47,0,0,BBg1.00,[M]Malignant lymphoma NOS,Feb-09,,,,,
36693,61,4,0,0,ZV10600,[V]Personal history of leukaemia,Feb-09,,,1,,
37112,4,0,0,0,B6...11,MALIGNANT NEOPLASM OF HISTIOCYTIC TISSUE,,,,,,
37182,78,3,0,0,B63..00,Multiple myeloma and immunoproliferative neoplasms,Feb-09,,,,,
37272,95,1,0,0,B67..00,Other specified leukaemia,Feb-09,,,,,
37410,56,0,0,0,BBr2100,[M]Acute lymphoid leukaemia,Feb-09,,,,,
37461,17,0,0,0,B64y200,Adult T-cell leukaemia,Feb-09,,,,,
37487,5,0,0,0,BBrA700,[M]Acute myelofibrosis,Feb-09,,,,,
37723,44,1,0,0,BBr6011,[M]Granulocytic leukaemia NOS,Feb-09,,,,,
38005,24,1,0,0,B621z00,Mycosis fungoides NOS,Feb-09,,,,,
38331,15,0,0,0,B64yz00,Other lymphoid leukaemia NOS,Feb-09,,,,,
38914,47,1,0,0,B64z.00,Lymphoid leukaemia NOS,Feb-09,,,,,
38939,27,0,0,0,B613.00,"Hodgkin's disease, lymphocytic-histiocytic predominance",Feb-09,,,,,
39187,87,3,0,0,B631.00,Plasma cell leukaemia,Feb-09,,,,,
39336,10,1,0,0,B6y1.00,Myelosclerosis with myeloid metaplasia,Feb-09,,,,,
39490,27,0,0,0,BBn0.14,[M]PLASMACYTIC MYELOMA,,,,,,
39798,96,1,0,0,B627X00,"Diffuse non-Hodgkin's lymphoma, unspecified",Feb-09,,,,,
39883,4,0,0,0,BBk5.00,"[M]Malig lymp, follicular centre cell, cleaved, follicular",Oct-09,,,,,
39906,3,0,0,0,BBgE.00,"[M]Malignant lymphoma, centrocytic",Feb-09,,,,,
40420,5,0,0,0,BBr0.00,[M]Leukaemias unspecified,Feb-09,,,,,
40508,3,0,0,0,BBj6000,"[M]Hodgkin,s disease, nodular sclerosis, lymphocytic predom",Feb-09,,,,,
40513,53,1,0,0,BBkz.00,"[M]Lymphoma, nodular or follicular NOS",Feb-09,,,,,
40561,56,3,0,0,ZV10711,[V]Personal history of Hodgkin's disease,Feb-09,,,1,,
40740,32,0,0,0,ByuD.00,"[X]Malignant neoplasms of lymphoid, haematopoietic and rela",Feb-09,,,,,
40766,150,2,0,0,BBm5.00,[M] Peripheral T-cell lymphoma NOS,Feb-09,,,,,
40991,30,1,23,0,4M2..00,Lymphoma staging system,Feb-09,,,,,
41369,3,0,0,0,B60..00,Lymphosarcoma and reticulosarcoma,Feb-09,,,,,
41500,45,2,0,0,BBr2300,[M]Chronic lymphoid leukaemia,Feb-09,,,,,
41734,13,1,0,0,BBr0000,[M]Leukaemia NOS,Feb-09,,,,,
41754,46,10,0,0,BBg7.00,"[M]Malignant lymphoma, lymphoplasmacytoid type",Feb-09,,,,,
41841,10,0,0,0,BBgB.00,"[M]Malignant lymphoma, follicular centre cell NOS",Feb-09,,,,,
42198,22,1,0,0,BBj6.00,"[M]Hodgkin's disease, nodular sclerosis NOS",Feb-09,,,,,
42297,79,0,0,0,BBrz.00,[M]Leukaemia NOS,Feb-09,,,,,
42461,103,2,0,0,B61zz00,Hodgkin's disease NOS,Feb-09,,,,,
42539,52,2,0,0,B670.00,Acute erythraemia and erythroleukaemia,Feb-09,,,,,
42579,7,0,0,0,B62y300,Malignant lymphoma NOS of intra-abdominal lymph nodes,Feb-09,,,,,
42769,8,0,0,0,BBjz.00,[M]Hodgkin's disease NOS,Feb-09,,,,,
43415,10,0,0,0,ByuD000,[X]Other Hodgkin's disease,Feb-09,,,,,
43450,40,0,0,0,B63z.00,Immunoproliferative neoplasm or myeloma NOS,Feb-09,,,,,
43459,32,1,0,0,BBn..00,[M]Plasma cell tumours,Feb-09,,,,,
43552,37,4,1,0,B630.11,KAHLER'S DISEASE,,,,,,
44196,11,1,0,0,B611.00,Hodgkin's granuloma,Feb-09,,,,,
44267,49,5,1,0,B623.00,MALIGNANT HISTIOCYTOSIS,,,,,,
44318,99,7,0,0,B62xX00,Oth and unspecif peripheral & cutaneous T-cell lymphomas,Feb-09,,,,,
44617,11,0,0,0,A789600,HIV disease resulting in Burkitt's lymphoma,Feb-09,,,,,
45143,9,1,0,0,ByuHD00,"[X]Myelodysplastic syndrome, unspecified",Feb-09,,,,,
45264,14,0,0,0,B620100,"Nodular lymphoma of lymph nodes of head, face and neck",Feb-09,,,,,
45285,635,24,0,0,B937W00,"Myelodysplastic syndrome, unspecified",Feb-09,,,,,
45768,23,0,0,0,BBm3.12,[M]ACUTE PROGRESSIVE HISTIOCYTOSIS X,,,,,,
46042,81,0,0,0,B630300,LAMBDA LIGHT CHAIN MYELOMA,,,,,,
46048,5,0,0,0,BBr2500,[M]Prolymphocytic leukaemia,Feb-09,,,,,
46263,54,4,0,0,BBr6700,[M]Acute myelomonocytic leukaemia,Feb-09,,,,,
46444,16,1,0,0,BBr4.00,[M]Erythroleukaemias,Feb-09,,,,,
46877,25,1,0,0,BBgL.00,"[M]Malignant lymphoma, small lymphocytic NOS",Feb-09,,,,,
46931,3,0,0,0,BBg4.00,"[M]Malignant lymphoma, stem cell type",Feb-09,,,,,
46967,67,3,0,0,BBl..00,[M]Mycosis fungoides,Feb-09,,,,,
47204,5,1,0,0,B625z00,LETTERER-SIWE DISEASE NOS,,,,,,
47330,2,0,0,0,BBm2.00,[M]HISTIOCYTIC MEDULLARY RETICULOSIS,,,,,,
48049,13,0,0,0,BBr6800,[M]Chronic myelomonocytic leukaemia,Feb-09,,,,,
48155,13,1,0,0,BBr2.00,[M]Lymphoid leukaemias,Feb-09,,,,,
48253,7,0,0,0,BBg8.00,"[M]Malignant lymphoma, immunoblastic type",Feb-09,,,,,
49131,14,1,0,0,BBg0.00,"[M]Lymphomatous tumour, benign",Feb-09,,,,,
49253,10,0,0,0,BBk0.13,[M]Giant follicular lymphoma,Apr-10,,,,,
49262,31,2,0,0,B627200,Follicular non-Hodgkin's large cell lymphoma,Feb-09,,,,,
49301,302,15,0,0,B6z..00,MALIGNANT NEOPLASM LYMPHATIC OR HAEMATOPOIETIC TISSUE NOS,,,,,,
49327,6,0,0,0,BBrA500,[M]Acute megakaryoblastic leukaemia,Feb-09,,,,,
49530,68,3,3,0,BBmC.00,[M] T-gamma lymphoproliferative disease,Feb-09,,,,,
49605,34,1,0,0,B615.00,"Hodgkin's disease, mixed cellularity",Feb-09,,,,,
49725,10,0,0,0,B64y.00,Other lymphoid leukaemia,Feb-09,,,,,
49825,20,0,0,0,BBh0.11,[M]RETICULUM CELL SARCOMA NOS,Feb-09,,,,,
50668,9,0,0,0,B627300,Diffuse non-Hodgkin's small cell (diffuse) lymphoma,Feb-09,,,,,
50695,9,0,0,0,B627500,Diffuse non-Hodgkin mixed sml & lge cell (diffuse) lymphoma,Feb-09,,,,,
50696,23,0,0,0,B62y100,"Malignant lymphoma NOS of lymph nodes of head, face and neck",Feb-09,,,,,
50858,3,0,0,0,B674.00,ACUTE PANMYELOSIS,,,,,,
50928,4,0,0,0,BBr2600,[M]Burkitt's cell leukaemia,Feb-09,,,,,
51285,9,0,0,0,BBj2.00,"[M]Hodgkin's disease, mixed cellularity",Apr-09,,,,,
51680,8,0,0,0,BBgV.00,"[M]Malignant lymphoma, small cell, noncleaved, diffuse",Feb-09,,,,,
51852,1,0,0,0,BBgD.00,"[M]Malig lymphoma, lymphocytic, intermediate different NOS",Feb-09,,,,,
51895,56,1,0,0,BBgz.00,"[M]Lymphoma, diffuse or NOS",Feb-09,,,,,
52327,15,1,0,0,B653000,Chloroma,Feb-09,,,,,
52591,11,0,0,0,BBgG.13,[M]Lymphoblastoma NOS,Feb-09,,,,,
52593,4,2,2,0,BBmE.00,[M] GAMMA HEAVY CHAIN DISEASE,,,,,,
52942,13,1,0,0,BBr6300,[M]Chronic myeloid leukaemia,Feb-09,,,,,
52946,1,0,7,0,4C53.00,BONE MARROW: MYELOMA CELLS,,,,,,
53397,146,6,0,0,B61z.00,Hodgkin's disease NOS,Feb-09,,,,,
53477,10,0,0,0,ZV67811,[V]Follow-up examination after chemotherapy for leukaemia,,,,,,
53551,7,0,0,0,B627600,Diffuse non-Hodgkin's immunoblastic (diffuse) lymphoma,Feb-09,,,,,
53647,12,0,0,0,BBn0.13,[M]MYELOMATOSIS,,,,,,
54083,1,0,0,0,B625800,LETTERER-SIWE DISEASE OF LYMPH NODES OF MULTIPLE SITES,,,,,,
54190,32,0,0,0,BBm8.00,[M] Angioimmunoblastic lymphadenopathy,Feb-09,,,,,
54585,43,0,0,0,BBr6100,[M]Acute myeloid leukaemia,Feb-09,,,,,
54793,3,0,0,0,B682.00,Subacute leukaemia NOS,Feb-09,,,,,
55303,14,0,0,0,B614100,"Hodgkin's nodular sclerosis of head, face and neck",Feb-09,,,,,
56041,7,0,0,0,BBj1.00,"[M]Hodgkin's disease, lymphocytic predominance",Feb-09,,,,,
57225,5,0,0,0,B614000,"Hodgkin's disease, nodular sclerosis of unspecified site",Feb-09,,,,,
57316,29,0,0,0,BBr6600,[M]Acute promyelocytic leukaemia,Feb-09,,,,,
57427,24,1,0,0,B62y000,Malignant lymphoma NOS of unspecified site,Feb-09,,,,,
57544,7,0,0,0,BBm4.00,[M]True histiocytic lymphoma,Feb-09,,,,,
57671,7,0,0,0,B672.00,Megakaryocytic leukaemia,Feb-09,,,,,
57713,1,0,0,0,BBr8.00,[M]Eosinophilic leukaemias,Feb-09,,,,,
57737,4,0,0,0,B62x100,Lymphoepithelioid lymphoma,Feb-09,,,,,
58015,8,0,0,0,BBgQ.00,[M]Malignant lymphomatous polyposis,Feb-09,,,,,
58082,3,0,0,0,B620800,Nodular lymphoma of lymph nodes of multiple sites,Feb-09,,,,,
58684,2,0,0,0,B615200,Hodgkin's mixed cellularity of intrathoracic lymph nodes,Feb-09,,,,,
58871,6,0,0,0,B623z00,MALIGNANT HISTIOCYTOSIS NOS,,,,,,
58953,1,0,0,0,BBk8.00,"[M]Malig lymp,follicular centre cell,noncleaved,follicular",Feb-09,,,,,
58962,3,0,0,0,B62x500,Malignant immunoproliferative small intestinal disease,Feb-09,,,,,
59115,3,0,0,0,B602100,"Burkitt's lymphoma of lymph nodes of head, face and neck",Feb-09,,,,,
59593,11,1,0,0,BBm3.00,[M]LETTERER - SIWE DISEASE,,,,,,
59755,16,0,0,0,B61z200,Hodgkin's disease NOS of intrathoracic lymph nodes,Feb-09,,,,,
59778,17,0,0,0,B61z100,"Hodgkin's disease NOS of lymph nodes of head, face and neck",Feb-09,,,,,
59929,2,0,0,0,BBr0z00,"[M]Leukaemia unspecified, NOS",Feb-09,,,,,
60092,12,0,0,0,B62y700,Malignant lymphoma NOS of spleen,Feb-09,,,,,
60242,1,0,0,0,B600000,Reticulosarcoma of unspecified site,Feb-09,,,,,
60275,7,0,0,0,BBgJ.00,"[M]Malignant lymphoma, centroblastic type NOS",Feb-09,,,,,
60433,14,0,0,0,N330900,OSTEOPOROSIS IN MULTIPLE MYELOMATOSIS,,,,,,
60504,1,0,0,0,BBgC.12,[M]Lymphocytic lymphosarcoma NOS,Feb-09,,,,,
60918,1,0,15,0,4M20.00,Lymphoma stage I,Feb-09,,,,,
61146,4,0,0,0,BBmF.00,[M] Angiocentric immunoproliferative lesion,Feb-09,,,,,
61149,2,0,0,0,B614300,Hodgkin's nodular sclerosis of intra-abdominal lymph nodes,Feb-09,,,,,
61251,2,0,0,0,BBgN.00,"[M]Malign lymphoma,lymphocytic,intermediate differn, diffuse",Feb-09,,,,,
61500,7,0,0,0,B690.00,Acute myelomonocytic leukaemia,Feb-09,,,,,
61662,8,0,0,0,B61z000,"Hodgkin's disease NOS, unspecified site",Feb-09,,,,,
61693,7,0,0,0,ByuD600,[X]Other myeloid leukaemia,Feb-09,,,,,
61997,21,0,0,0,BBj0.00,[M]Hodgkin's disease NOS,Feb-09,,,,,
62330,2,0,0,0,BBr6z00,[M]Other myeloid leukaemia NOS,Feb-09,,,,,
62380,1,0,0,0,B601200,Lymphosarcoma of intrathoracic lymph nodes,Feb-09,,,,,
62437,4,0,0,0,B62x400,Malignant reticulosis,Feb-09,,,,,
63054,26,0,0,0,B614z00,"Hodgkin's disease, nodular sclerosis NOS",Feb-09,,,,,
63105,7,0,0,0,B62y500,Malignant lymphoma NOS of lymph node inguinal region and leg,Feb-09,,,,,
63239,6,0,0,0,BBm1.00,[M]MALIGNANT HISTIOCYTOSIS,,,,,,
63375,25,0,0,0,ByuDE00,[X]Unspecified B-cell non-Hodgkin's lymphoma,Feb-09,,,,,
63475,4,0,0,0,B652.00,Subacute myeloid leukaemia,Feb-09,,,,,
63570,3,0,0,0,BBr0113,[M]Stem cell leukaemia,Feb-09,,,,,
63625,0,1,0,0,B616400,Hodgkin's lymphocytic depletion lymph nodes axilla and arm,Feb-09,,,,,
63699,12,2,0,0,BBk0.00,"[M]Malignant lymphoma, nodular NOS",Feb-09,,,,,
63723,11,0,0,0,B601z00,Lymphosarcoma NOS,Feb-09,,,,,
63973,1,0,0,0,BBm0.00,[M]Microglioma,Feb-09,,,,,
63994,1,0,0,0,BBgS.00,"[M]Malignant lymphoma, large cell, cleaved, diffuse",Feb-09,,,,,
64036,3,0,0,0,B612.00,Hodgkin's sarcoma,Feb-09,,,,,
64068,5,0,0,0,BBnz.00,[M]Plasma cell tumour NOS,Feb-09,,,,,
64336,7,0,0,0,ByuD300,[X]Other specified types of non-Hodgkin's lymphoma,Aug-11,,,,,
64343,8,0,0,0,BBj6100,"[M]Hodgkin,s disease, nodular sclerosis, mixed cellularity",Feb-09,,,,,
64427,5,0,0,0,B62z100,UNSPEC MALIG NEOP LYMPHOID/HISTIOCYTIC LYMPH NODE HEAD/NECK,,,,,,
64515,3,0,0,0,ByuDC00,"[X]Diffuse non-Hodgkin's lymphoma, unspecified",Feb-09,,,,,
64567,12,0,0,0,B63y.00,Other immunoproliferative neoplasms,Feb-09,,,,,
64618,3,0,0,0,BBr3.00,[M]Plasma cell leukaemias,Feb-09,,,,,
64670,1,0,0,0,B601300,Lymphosarcoma of intra-abdominal lymph nodes,Feb-09,,,,,
64947,1,0,0,0,BBk0.11,[M]Brill - Symmers' disease,Feb-09,,,,,
64963,8,0,0,0,BBr0112,[M]Blastic leukaemia,Feb-09,,,,,
65122,2,0,0,0,B624000,Leukaemic reticuloendotheliosis of unspecified sites,Feb-09,,,,,
65123,1,0,0,0,B624300,Leukaemic reticuloend of intra-abdominal lymph nodes,Feb-09,,,,,
65165,1,0,0,0,ByuD900,[X]Other leukaemia of unspecified cell type,Feb-09,,,,,
65180,9,0,0,0,B627800,Diffuse non-Hodgkin's lymphoma undifferentiated (diffuse),Feb-09,,,,,
65434,2,0,0,0,B62z.00,MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE NOS,,,,,,
65483,2,0,0,0,B614400,Hodgkin's nodular sclerosis of lymph nodes of axilla and arm,Feb-09,,,,,
65489,2,0,0,0,B610.00,Hodgkin's paragranuloma,Feb-09,,,,,
65584,2,0,0,0,BBj1000,"[M]Hodgkin,s disease, lymphocytic predominance, diffuse",Feb-09,,,,,
65642,2,0,0,0,B623300,MALIGNANT HISTIOCYTOSIS OF INTRA-ABDOMINAL LYMPH NODES,,,,,,
65701,20,1,0,0,B620z00,Nodular lymphoma NOS,Feb-09,,,,,
65721,2,0,0,0,B673.00,Mast cell leukaemia,Feb-09,,,,,
65777,8,1,0,0,B672.11,Thrombocytic leukaemia,Feb-09,,,,,
66089,2,0,0,0,B65yz00,Other myeloid leukaemia NOS,Feb-09,,,,,
66327,8,0,0,0,B620000,Nodular lymphoma of unspecified site,Feb-09,,,,,
66367,7,0,0,0,A789700,HIV dis resulting oth types of non-Hodgkin's lymphoma,Feb-09,,,,,
66603,12,0,0,0,BBgK.00,"[M]Malig lymphoma, follicular centre cell, non-cleaved NOS",Feb-09,,,,,
66694,1,0,0,0,BBr6311,[M]Naegeli-type monocytic leukaemia,Feb-09,,,,,
67029,7,0,0,0,ByuD500,[X]Other lymphoid leukaemia,Feb-09,,,,,
67339,1,0,0,0,BBp2.00,[M]MALIGNANT MASTOCYTOSIS,,,,,,
67506,5,0,0,0,B614200,Hodgkin's nodular sclerosis of intrathoracic lymph nodes,Feb-09,,,,,
67518,3,0,0,0,ByuD100,[X]Other types of follicular non-Hodgkin's lymphoma,Mar-10,,,,,
67700,3,0,0,0,B66..12,Monoblastic leukaemia,Feb-09,,,,,
67703,5,0,0,0,B616.00,"Hodgkin's disease, lymphocytic depletion",Feb-09,,,,,
68039,0,0,0,0,B612400,Hodgkin's sarcoma of lymph nodes of axilla and upper limb,Feb-09,,,,,
68330,7,0,0,0,B613100,"Hodgkin's, lymphocytic-histiocytic pred of head, face, neck",Feb-09,,,,,
68353,1,0,0,0,BBmJ.00,[M] Angioendotheliomatosis,Feb-09,,,,,
68964,2,0,0,0,BBgA.00,"[M]Malignant lymphoma, centroblastic-centrocytic, diffuse",Feb-09,,,,,
69299,1,1,0,0,BBrA111,[M]Thrombocytic leukaemia,Jun-09,,,,,
69301,1,0,0,0,BBg5.00,"[M]Malignant lymphoma, convoluted cell type NOS",Feb-09,,,,,
69497,1,0,0,0,B623000,MALIGNANT HISTIOCYTOSIS OF UNSPECIFIED SITE,,,,,,
69767,1,0,0,0,AyuC600,[X]HIV disease resulting in other non-Hodgkin's lymphoma,Feb-09,,,,,
69980,18,1,0,0,BBgC.00,"[M]Malignant lymphoma, lymphocytic, well differentiated NOS",Feb-09,,,,,
70374,1,0,0,0,B600300,Reticulosarcoma of intra-abdominal lymph nodes,Feb-09,,,,,
70509,5,0,0,0,B627D00,Diffuse non-Hodgkin's centroblastic lymphoma,Feb-09,,,,,
70716,2,0,0,0,B62zz11,Immunoproliferative neoplasm,Feb-09,,,,,
70724,4,1,0,0,B653.00,Myeloid sarcoma,Feb-09,,,,,
70740,1,0,0,0,BBm1.11,[M]Malignant reticulosis,Feb-09,,,,,
70842,2,0,0,0,B627100,Follicular non-Hodg mixed sml cleavd & lge cell lymphoma,Feb-09,,,,,
70935,1,0,0,0,BBr4000,[M]Erythroleukaemia,Nov-10,,,,,
71031,1,0,0,0,B600100,"Reticulosarcoma of lymph nodes of head, face and neck",Feb-09,,,,,
71117,2,0,0,0,BBg3.00,"[M]Malignant lymphoma, undifferentiated cell type NOS",Feb-09,,,,,
71142,2,0,0,0,B613000,"Hodgkin's, lymphocytic-histiocytic predominance unspec site",Feb-09,,,,,
71238,4,0,0,0,B601100,"Lymphosarcoma of lymph nodes of head, face and neck",Feb-09,,,,,
71262,4,0,0,0,B62y600,Malignant lymphoma NOS of intrapelvic lymph nodes,Feb-09,,,,,
71304,8,0,0,0,B602z00,Burkitt's lymphoma NOS,Feb-09,,,,,
71377,1,0,0,0,BBr8000,[M]Eosinophilic leukaemia,Feb-09,,,,,
71609,3,1,0,0,B62z500,UNSPEC MALIG NEOP LYMPHOID/HISTIOCYTIC NODES INGUINAL/LEG,,,,,,
71619,1,0,0,0,BBgT.00,"[M]Malignant lymphoma, large cell, noncleaved, diffuse",Feb-09,,,,,
71625,1,0,0,0,B601000,Lymphosarcoma of unspecified site,Feb-09,,,,,
71652,2,0,0,0,BBgP.00,"[M]Malignant lymphoma, mixed small and large cell, diffuse",Feb-09,,,,,
71672,7,0,10,0,4M23.00,Lymphoma stage IV,Feb-09,,,,,
71850,4,1,0,0,BBr6000,[M]Myeloid leukaemia NOS,Feb-09,,,,,
72179,1,0,0,0,BBr0200,[M]Subacute leukaemia NOS,Feb-09,,,,,
72196,5,1,0,0,BBgG.00,"[M]Malignant lymphoma, lymphocytic, poorly different NOS",Feb-09,,,,,
72197,2,0,0,0,B67y000,Lymphosarcoma cell leukaemia,Feb-09,,,,,
72222,1,0,0,0,BBrA100,[M]Megakaryocytic leukaemia,Feb-09,,,,,
72310,1,1,0,0,BBr0400,[M]Aleukaemic leukaemia NOS,Feb-09,,,,,
72433,2,0,0,0,BBh0.00,[M]Reticulosarcoma NOS,Feb-09,,,,,
72500,2,0,0,0,ByuDB00,"[X]Mal neoplasm/lymphoid,haematopoietic+related tissu,unspcf",Feb-09,,,,,
72714,3,0,0,0,B621500,Mycosis fungoides of lymph nodes of inguinal region and leg,Feb-09,,,,,
72725,6,0,0,0,B62y200,Malignant lymphoma NOS of intrathoracic lymph nodes,Feb-09,,,,,
72774,1,0,0,0,B642.00,Subacute lymphoid leukaemia,Feb-09,,,,,
73066,1,0,0,0,BBrA.00,[M]Miscellaneous leukaemias,Feb-09,,,,,
73532,1,0,0,0,B613300,"Hodgkin's, lymphocytic-histiocytic pred intra-abdominal node",Feb-09,,,,,
73777,2,0,0,0,B624z00,Leukaemic reticuloendotheliosis NOS,Feb-09,,,,,
87335,165,9,0,0,B624.12,Hairy cell leukaemia,Feb-09,,,,,
89230,1,0,0,0,BBj9.00,[M]Hodgkin's granuloma,Feb-09,,,,,
89329,3,0,0,0,ByuD800,[X]Other specified leukaemias,Feb-09,,,,,
89657,1,0,0,0,B626z00,MALIGNANT MAST CELL TUMOUR NOS,,,,,,
89762,1,0,0,0,ByuD700,[X]Other monocytic leukaemia,Feb-09,,,,,
90201,4,0,0,0,B62x000,T-zone lymphoma,Feb-09,,,,,
91674,1,0,0,0,B621300,Mycosis fungoides of intra-abdominal lymph nodes,Feb-09,,,,,
91900,4,0,0,0,B61z400,Hodgkin's disease NOS of lymph nodes of axilla and arm,Feb-09,,,,,
92068,4,0,0,0,B620300,Nodular lymphoma of intra-abdominal lymph nodes,Feb-09,,,,,
92245,1,0,0,0,B613200,"Hodgkin's, lymphocytic-histiocytic pred intrathoracic nodes",Feb-09,,,,,
92380,1,0,0,0,B602500,Burkitt's lymphoma of lymph nodes of inguinal region and leg,Feb-09,,,,,
93342,2,0,0,0,B66z.00,Monocytic leukaemia NOS,Feb-09,,,,,
93384,2,0,0,0,B62z200,UNSPEC MALIG NEOP LYMPHOID/HISTIOCYTIC OF INTRATHORACIC NODE,,,,,,
93951,2,0,0,0,B613500,"Hodgkin's, lymphocytic-histiocytic pred inguinal and leg",Feb-09,,,,,
94005,18,0,0,0,B615z00,"Hodgkin's disease, mixed cellularity NOS",Feb-09,,,,,
94174,5,0,0,0,B67y.00,Other and unspecified leukaemia,Feb-09,,,,,
94239,1,0,0,0,BBp1.00,[M]MAST CELL SARCOMA,,,,,,
94279,1,0,0,0,B61z700,Hodgkin's disease NOS of spleen,Feb-09,,,,,
94407,3,0,0,0,B615100,"Hodgkin's mixed cellularity of lymph nodes head, face, neck",Feb-09,,,,,
94415,2,0,0,0,B623100,"MALIGNANT HISTIOCYTOSIS OF LYMPH NODES HEAD, FACE AND NECK",,,,,,
94597,2,0,0,0,ZV10611,[V]Personal history of lymphoid leukaemia,Feb-09,,,1,,
94935,1,0,7,0,4M21.00,Lymphoma stage II,Feb-09,,,,,
94995,5,0,0,0,B620500,Nodular lymphoma of lymph nodes of inguinal region and leg,Feb-09,,,,,
95012,2,0,0,0,B621800,Mycosis fungoides of lymph nodes of multiple sites,Feb-09,,,,,
95049,2,0,0,0,B616000,Hodgkin's lymphocytic depletion of unspecified site,Feb-09,,,,,
95058,1,0,0,0,B600700,Reticulosarcoma of spleen,Feb-09,,,,,
95338,2,0,0,0,B613600,"Hodgkin's, lymphocytic-histiocytic pred intrapelvic nodes",Feb-09,,,,,
95464,1,0,0,0,BBl0.00,[M]Mycosis fungoides,Oct-09,,,,,
95545,17,0,0,0,B627911,Maltoma,Feb-09,,,,,
95630,1,0,0,0,B62x600,True histiocytic lymphoma,Feb-09,,,,,
95715,10,0,0,0,B627900,Mucosa-associated lymphoma,Feb-09,,,,,
95792,2,0,0,0,B62zz00,LYMPHOID AND HISTIOCYTIC MALIGNANCY NOS,,,,,,
95949,11,0,0,0,B621000,Mycosis fungoides of unspecified site,Feb-09,,,,,
96183,1,0,0,0,BBj4.00,"[M]Hodgkin's disease,lymphocytic depletion,diffuse fibrosis",Feb-09,,,,,
96379,1,0,0,0,B621400,Mycosis fungoides of lymph nodes of axilla and upper limb,Apr-09,,,,,
96893,3,0,0,0,BBrA300,[M]Myeloid sarcoma,Nov-09,,,,,
97577,1,0,0,0,B602300,Burkitt's lymphoma of intra-abdominal lymph nodes,Sep-09,,,,,
97746,4,0,0,0,B61z800,Hodgkin's disease NOS of lymph nodes of multiple sites,Oct-09,,,,,
97756,2,0,0,0,BBl1.00,[M]Sezary's disease,Jun-10,,,,,
97852,3,0,0,0,BBk7.00,"[M]Malignant lymphoma, centroblastic type, follicular",Feb-09,,,,,
97863,2,0,0,0,B615000,"Hodgkin's disease, mixed cellularity of unspecified site",Oct-09,,,,,
98009,2,0,0,0,BBrA312,[M]Granulocytic sarcoma,Feb-09,,,,,
98596,2,0,0,0,ByuD200,[X]Other types of diffuse non-Hodgkin's lymphoma,Feb-09,,,,,
98840,1,0,0,0,B610300,Hodgkin's paragranuloma of intra-abdominal lymph nodes,Mar-10,,,,,
98909,1,0,0,0,B611100,"Hodgkin's granuloma of lymph nodes of head, face and neck",Apr-10,,,,,
98961,1,0,0,0,BBk2.00,"[M]Malignant lymphoma, centroblastic-centrocytic, follicular",Feb-09,,,,,
99012,1,0,0,0,B61z500,Hodgkin's disease NOS of lymph nodes inguinal region and leg,Apr-10,,,,,
99015,1,0,0,0,B66y.00,Other monocytic leukaemia,Apr-10,,,,,
99067,1,0,0,0,C333200,GAMMA HEAVY CHAIN DISEASE,,,,,,
99200,1,0,0,0,BBj7.00,"[M]Hodgkin's disease, nodular sclerosis, cellular phase",Feb-09,,,,,
99240,1,0,0,0,B600z00,Reticulosarcoma NOS,Apr-10,,,,,
99413,4,0,0,0,B67yz00,Other and unspecified leukaemia NOS,May-10,,,,,
99655,1,0,0,0,BBg6.00,[M]Lymphosarcoma NOS,Jun-10,,,,,
99695,2,0,0,0,BBlz.00,[M]Mycosis fungoides NOS,Feb-09,,,,,
99702,2,0,0,0,BBn3.00,"[M]Plasma cell tumour, malignant",Jun-10,,,,,
99847,35,0,0,0,SP08A00,Post-transplant lymphoproliferative disorder,Jun-10,,,,,
99887,2,0,0,0,B60y.00,Other specified reticulosarcoma or lymphosarcoma,Jun-10,,,,,
99951,3,0,0,0,B60z.00,Reticulosarcoma or lymphosarcoma NOS,Jun-10,,,,,
100006,1,0,0,0,B602200,Burkitt's lymphoma of intrathoracic lymph nodes,Jun-10,,,,,
100352,2,0,0,0,B601500,Lymphosarcoma of lymph nodes of inguinal region and leg,Jul-10,,,,,
100423,1,0,0,0,B610100,"Hodgkin's paragranuloma of lymph nodes of head, face, neck",Aug-10,,,,,
100532,3,0,0,0,B622z00,Sezary's disease NOS,Aug-10,,,,,
100544,1,0,0,0,BBh2.00,"[M]Reticulosarcoma, nodular",Aug-10,,,,,
100615,1,0,0,0,B626500,Mast cell malignancy of lymph nodes inguinal region and leg,Sep-10,,,,,
100786,2,0,0,0,B651000,Chronic eosinophilic leukaemia,Nov-10,,,,,
100927,1,0,0,0,BBr4z00,[M]Erythroleukaemia NOS,Feb-09,,,,,
101114,20,0,0,0,B627A00,Diffuse non-Hodgkin's large cell lymphoma,Dec-10,,,,,
101271,1,0,0,0,BBs1.00,[M]Acute panmyelosis,Jan-11,,,,,
101350,2,0,0,0,C333100,Alpha heavy chain disease,Jan-11,,,,,
101429,1,0,0,0,BBj0.11,"[M]Lymphogranuloma, malignant",Jan-11,,,,,
101465,2,0,0,0,B62z800,Unspec malig neop lymphoid/histiocytic of multiple sites,Jan-11,,,,,
101530,1,0,0,0,B616z00,"Hodgkin's disease, lymphocytic depletion NOS",Jan-11,,,,,
101606,1,0,0,0,B662.00,Subacute monocytic leukaemia,Feb-11,,,,,
101715,1,0,0,0,B616700,"Hodgkin's disease, lymphocytic depletion of spleen",Feb-11,,,,,
102158,1,0,0,0,B625200,Letterer-Siwe disease of intrathoracic lymph nodes,Apr-11,,,,,
102594,28,0,0,0,B627E00,Diffuse large B-cell lymphoma,Jul-11,,,,,
102688,1,0,0,0,ByuD400,[X]Other malignant immunoproliferative diseases,Feb-09,,,,,
102715,1,0,0,0,B625000,Letterer-Siwe disease of unspecified sites,Aug-11,,,,,
102764,1,0,0,0,BBrA600,[M]Acute panmyelosis,Aug-11,,,,,
102783,1,0,0,0,B651200,Chronic neutrophilic leukaemia,Aug-11,,,,,
103245,1,0,0,0,B601700,Lymphosarcoma of spleen,Oct-11,,,,,
103353,1,0,0,0,B62z300,Unspec malig neop lymphoid/histiocytic intra-abdominal nodes,Dec-11,,,,,
103645,1,0,0,0,B66yz00,Other monocytic leukaemia NOS,Jan-12,,,,,
103900,3,0,0,0,B626000,Mast cell malignancy of unspecified site,Mar-12,,,,,
104152,688,6,0,0,B628.00,Follicular lymphoma,Jun-12,,,,,
104273,276,21,0,0,B677.00,Myelodysplastic and myeloproliferative disease,Jun-12,,,,,
104291,308,7,0,0,B61..11,Hodgkin lymphoma,Jun-12,,,,,
104325,111,0,0,0,B640000,B-cell acute lymphoblastic leukaemia,Jun-12,,,,,
104328,113,2,0,0,B641000,B-cell chronic lymphocytic leukaemia,Jun-12,,,,,
104386,112,0,0,0,B62F000,Small cell B-cell lymphoma,Jun-12,,,,,
104391,133,0,0,0,B627.11,Non-Hodgkin lymphoma,Jun-12,,,,,
104412,7,0,0,0,B62F200,Lymphoblastic (diffuse) lymphoma,Jun-12,,,,,
104475,1,0,0,0,B692.00,Subacute myelomonocytic leukaemia,Jul-12,,,,,
104484,14,0,0,0,B61C.00,Other classical Hodgkin lymphoma,Jul-12,,,,,
104620,239,0,0,0,B62F100,Mantle cell lymphoma,Jul-12,,,,,
104743,1,0,0,0,B613800,"Hodgkin's, lymphocytic-histiocytic pred of multiple sites",Aug-12,,,,,
104788,9,1,0,0,B654.00,Acute myeloblastic leukaemia,Aug-12,,,,,
104790,1,0,0,0,B601800,Lymphosarcoma of lymph nodes of multiple sites,Aug-12,,,,,
104862,18,0,0,0,B62E300,Cutaneous T-cell lymphoma,Aug-12,,,,,
104895,15,0,0,0,B617.00,Nodular lymphocyte predominant Hodgkin lymphoma,Aug-12,,,,,
104934,2,0,0,0,B62Ew00,Other mature T/NK-cell lymphoma,Sep-12,,,,,
104939,10,0,0,0,B64y500,Adult T-cell lymphoma/leukaemia (HTLV-1-associated),Sep-12,,,,,
105020,6,0,0,0,B628300,Follicular lymphoma grade 3a,Sep-12,,,,,
105025,3,0,0,0,ByuDA00,"[X]Oth spcf mal neoplsm/lymphoid,haematopoietic+rltd tissue",Oct-12,,,,,
105038,15,0,0,0,B627G00,Mediastinal (thymic) large B-cell lymphoma,Oct-12,,,,,
105069,3,0,0,0,B693.00,Juvenile myelomonocytic leukaemia,Oct-12,,,,,
105083,13,0,0,0,B62D.00,Histiocytic sarcoma,Oct-12,,,,,
105085,35,0,0,0,B62E.00,T/NK-cell lymphoma,Oct-12,,,,,
105095,16,0,0,0,B628100,Follicular lymphoma grade 2,Oct-12,,,,,
105203,1,0,0,0,B620200,Nodular lymphoma of intrathoracic lymph nodes,Nov-12,,,,,
105286,7,0,0,0,B62EA00,Primary cutaneous CD30-positive T-cell proliferations,Dec-12,,,,,
105335,5,0,0,0,B62A.00,Sarcoma of dendritic cells,Dec-12,,,,,
105375,3,0,0,0,B62E800,Blastic NK-cell lymphoma,Dec-12,,,,,
105390,6,0,0,0,B937911,Myelodysplastic syndrome isolated del(5q) chromosomal abnorm,Dec-12,,,,,
105472,1,0,0,0,B614700,"Hodgkin's disease, nodular sclerosis of spleen",Dec-12,,,,,
105559,16,0,0,0,B62E100,"Anaplastic large cell lymphoma, ALK-positive",Jan-13,,,,,
105636,16,0,0,0,B62E900,Angioimmunoblastic T-cell lymphoma,Jan-13,,,,,
105709,2,0,0,0,B62E600,Enteropathy-associated T-cell lymphoma,Jan-13,,,,,
105762,6,0,0,0,B62C.00,Unifocal Langerhans-cell histiocytosis,Feb-13,,,,,
105792,6,0,0,0,B629.00,Multifocal multisystemic dissem Langerhans-cell histiocytosi,Feb-13,,,,,
105841,15,0,0,0,B618.00,Nodular sclerosis classical Hodgkin lymphoma,Mar-13,,,,,
105889,14,0,0,0,B628000,Follicular lymphoma grade 1,Mar-13,,,,,
105915,7,0,0,0,B937900,5Q minus syndrome,Apr-13,,,,,
105925,1,0,0,0,B62E700,Subcutaneous panniculitic T-cell lymphoma,Apr-13,,,,,
105955,12,0,0,0,B62E200,"Anaplastic large cell lymphoma, ALK-negative",Apr-13,,,,,
105957,6,0,0,0,B651100,"Chronic myeloid leukaemia, BCR/ABL positive",Apr-13,,,,,
105966,7,0,0,0,B627F00,Extranod marg zone B-cell lymphom mucosa-assoc lymphoid tiss,Apr-13,,,,,
106063,2,0,0,0,B628700,Other types of follicular lymphoma,May-13,,,,,
106137,1,0,0,0,BBh..00,[M]Reticulosarcomas,May-13,,,,,
106197,1,0,0,0,BBr7000,[M]Basophilic leukaemia,May-13,,,,,
106349,3,0,0,0,B61z.11,Hodgkin lymphoma NOS,Jun-13,,,,,
106483,1,0,0,0,BBr6200,[M]Subacute myeloid leukaemia,Aug-13,,,,,
106597,3,0,0,0,B61B.00,Lymphocyte-rich classical Hodgkin lymphoma,Aug-13,,,,,
106867,4,0,0,0,B62F.11,Non-follicular lymphoma,Aug-13,,,,,
106884,6,0,0,0,B62F.00,Nonfollicular lymphoma,Aug-13,,,,,
106911,1,0,0,0,B613700,"Hodgkin's, lymphocytic-histiocytic predominance of spleen",Aug-13,,,,,
106924,8,0,0,0,B641200,Clinical stage B chronic lymphocytic leukaemia,Aug-13,,,,,
106969,2,0,0,0,B628500,Diffuse follicle centre lymphoma,Sep-13,,,,,
106970,2,0,0,0,BBk3.00,"[M]Malig lymphoma, lymphocytic, well differentiated,nodular",Sep-13,,,,,
107017,9,0,0,0,B641011,Chronic lymphocytic leukaemia of B-cell type,Sep-13,,,,,
107032,1,0,0,0,B616800,Hodgkin's lymphocytic depletion lymph nodes multiple sites,Sep-13,,,,,
107052,39,0,0,0,B641100,Clinical stage A chronic lymphocytic leukaemia,Oct-13,,,,,
107163,3,0,0,0,B641300,Clinical stage C chronic lymphocytic leukaemia,Oct-13,,,,,
107166,5,0,0,0,B628200,Follicular lymphoma grade 3,Oct-13,,,,,
107236,6,0,0,0,B651300,"Atypical chronic myeloid leukaemia, BCR/ABL negative",Nov-13,,,,,
107638,1,0,0,0,B62z400,Unspec malig neop lymphoid/histiocytic lymph node axilla/arm,Jan-14,,,,,
107643,4,0,0,0,B64y400,T-cell prolymphocytic leukaemia,Jan-14,,,,,
107773,1,0,0,0,BBr8z00,[M]Eosinophilic leukaemia NOS,Mar-14,,,,,
107804,1,0,0,0,B61z300,Hodgkin's disease NOS of intra-abdominal lymph nodes,Mar-14,,,,,
107949,2,0,0,0,B62E500,Hepatosplenic T-cell lymphoma,Apr-14,,,,,
107973,5,0,0,0,B628400,Follicular lymphoma grade 3b,May-14,,,,,
108037,2,0,0,0,B62z000,Unspec malig neop lymphoid/histiocytic of unspecified site,May-14,,,,,
108102,3,0,0,0,C333300,Heavy chain disease,Jun-14,,,,,
108182,1,0,0,0,B627400,Diffuse non-Hodgkin's small cleaved cell (diffuse) lymphoma,Jun-14,,,,,
108235,1,0,0,0,C333011,Waldenstrom macroglobulinaemia,Jun-14,,,,,
108316,2,0,0,0,BBrAz00,[M]Miscellaneous leukaemia NOS,Jul-14,,,,,
108424,3,0,0,0,B663.00,Acute monoblastic leukaemia,Jul-14,,,,,
108656,3,1,0,0,B64y300,B-cell prolymphocytic leukaemia,Sep-14,,,,,
108715,1,0,0,0,B66..11,Histiocytic leukaemia,Oct-14,,,,,
108719,6,0,0,0,B628600,Cutaneous follicle centre lymphoma,Oct-14,,,,,
108775,1,0,0,0,B619.00,Mixed cellularity classical Hodgkin lymphoma,Oct-14,,,,,
108886,1,0,0,0,B615500,Hodgkin's mixed cellularity of lymph nodes inguinal and leg,Nov-14,,,,,
108964,2,0,0,0,BBr6900,[M]Juvenile myelomonocytic leukaemia,Dec-14,,,,,
109342,1,0,0,0,B62z600,Unspec malig neop lymphoid/histiocytic of intrapelvic nodes,Mar-15,,,,,
109714,1,0,0,0,ByuDD00,[X]Oth and unspecif peripheral & cutaneous T-cell lymphomas,Jun-15,,,,,
109780,1,0,0,0,B62E400,"Extranodal NK/T-cell lymphoma, nasal type",Jun-15,,,,,
110058,1,0,0,0,ZV10613,[V]Personal history of myeloid leukaemia,Sep-15,,,1,,
110191,2,0,0,0,B62B.00,Multifocal and unisystemic Langerhans-cell histiocytosis,Oct-15,,,,,
110349,1,0,0,0,BBr3z00,[M]Plasma cell leukaemia NOS,Dec-15,,,,,
110563,1,0,0,0,B616500,Hodgkin's lymphocytic depletion lymph nodes inguinal and leg,Feb-16,,,,,
110838,1,0,0,0,B676.00,Acute erythroid leukaemia,May-16,,,,,
110903,1,0,0,0,B623800,Malignant histiocytosis of lymph nodes of multiple sites,Jun-16,,,,,
111040,1,0,0,0,D401.12,Lipochrome histiocytosis - familial,Jul-16,,,,,
111113,1,0,0,0,BBj3.00,"[M]Hodgkin's disease, lymphocytic depletion NOS",Jul-16,,,,,
111627,1,0,0,0,B64y411,Prolymphocytic leukaemia of T-cell type,Jan-17,,,,,
111682,1,0,0,0,B62Fy00,Other non-follicular lymphoma,Mar-17,,,,,
111766,2,0,0,0,B620400,Nodular lymphoma of lymph nodes of axilla and upper limb,Apr-17,,,,,
111942,1,0,0,0,B616100,"Hodgkin's lymphocytic depletion of head, face and neck",Sep-17,,,,,
111980,1,0,0,0,A789611,HIV disease resulting in Burkitt lymphoma,Sep-17,,,,,
111981,1,0,0,0,A789711,HIV disease resulting in other types of non-Hodgkin lymphoma,Sep-17,,,,,
112033,1,0,0,0,AyuC611,[X]HIV disease resulting in other non-Hodgkin lymphoma,Sep-17,,,,,
112440,1,0,0,0,B65y.00,Other myeloid leukaemia,Jan-18,,,,,
112570,1,0,0,0,B623400,Malignant histiocytosis of lymph nodes of axilla and arm,Apr-18,,,,,
112729,1,0,0,0,BBh1.00,"[M]Reticulosarcoma, pleomorphic cell type",Jun-18,,,,,
67203,7,0,0,0,BBgG.11,[M]Lymphoblastic lymphosarcoma NOS,Feb-09,,,,,
27562,5,0,0,0,BBk0.12,[M]Follicular lymphosarcoma NOS,Feb-09,,,,,
72241,1,1,0,0,BBgH.00,[M]Prolymphocytic lymphosarcoma,Feb-09,,,,,
108682,1,0,0,0,BBgJ.11,[M]Germinoblastic sarcoma NOS,Oct-14,,,,,
938,3243,224,1,0,D201600,Pancytopenia NOS,Feb-09,,,,,
3129,546,43,24,0,C393.00,Unspecified immunity deficiency,Feb-09,,,,,
5823,2061,289,0,0,D201500,Pancytopenia - acquired,Feb-09,,,,,
22307,4893,6,0,0,2J31.00,Patient immunosuppressed,Feb-09,,,,,
35183,27,0,0,0,SL31.12,Immunosuppressive poisoning,Feb-09,,,,,
45940,39,0,0,0,U603400,[X]Immunosuppress agents caus adverse effects in therap use,Feb-09,,,,,
47106,3762,4,0,0,2J30.00,Patient immunocompromised,Feb-09,,,,,
48035,9,0,0,0,C391011,T-lymphocyte deficiency,Feb-09,,,,,
48307,25,1,0,0,C391.00,Deficiencies of cell-mediated immunity,Feb-09,,,,,
48547,133,0,0,0,7Q08.00,High cost immunosuppressant drugs,Feb-09,,,,,
50665,36,4,0,0,C391000,Predominantly T-cell immuno-deficiency NOS,Feb-09,,,,,
60076,2,0,2,0,5141.00,Radioth.for immunosuppression,Feb-09,,,,,
60758,4,0,0,0,C391012,Cellular immunity syndrome,Feb-09,,,,,
66386,8,1,0,0,Cyu0500,[X]Other specified immunodeficiency disorders,Feb-09,,,,,
102559,257,0,0,0,8BPE.00,Immunosuppressant drug therapy,Jul-11,,,,,
103417,3,0,0,0,7Q08z00,High cost immunosuppressant drugs NOS,Dec-11,,,,,
105256,543,1,0,0,8C32.00,Immunosuppressive therapy,Nov-12,,,,,
242,473,23,1,0,7901000,Allotransplantation of heart NEC,Feb-09,,,,,
250,204,5,0,0,7900.00,Transplantation of heart and lung,Feb-09,,,,,
2124,2027,54,0,0,8HBB.00,Transplant follow-up,Feb-09,,,,,1
2997,5914,147,3,0,7B00.00,Transplantation of kidney,Feb-09,,,,,
4405,1124,18,0,0,7800.00,Transplantation of liver,Feb-09,,,,,
4438,380,5,0,0,7901.00,Other transplantation of heart,Feb-09,,,,,
5504,2020,274,0,0,7B00z00,Transplantation of kidney NOS,Feb-09,,,,,
5911,1837,27,0,0,ZV42000,[V]Kidney transplanted,Feb-09,,,,,
6692,142,8,1,0,SP08600,Liver transplant failure and rejection,Feb-09,,,,,
9026,1332,29,0,0,ZV42700,[V]Liver transplanted,Feb-09,,,,,
9384,230,7,0,0,ZV42100,[V]Heart transplanted,Feb-09,,,,,
10394,245,5,0,0,ZV42600,[V]Lung transplanted,Feb-09,,,,,
10461,218,3,0,0,7450.00,Transplantation of lung,Feb-09,,,,,
11113,416,12,2,0,SP08100,Transplanted organ rejection,Feb-09,,,,,
11553,332,9,0,0,SP08300,Kidney transplant failure and rejection,Feb-09,,,,,
11745,2138,148,0,0,7B00100,Transplantation of kidney from live donor,Feb-09,,,,,
18774,184,6,0,0,TB00111,"Renal transplant with complication, without blame",Feb-09,,,,,
22653,79,0,0,0,ZV42.00,[V]Transplanted organ or tissue,Feb-09,,,,,
24361,557,4,0,0,7B00200,Transplantation of kidney from cadaver,Feb-09,,,,,
25896,28,0,0,0,SP08z00,Transplanted organ complication NOS,Feb-09,,,,,
26862,210,11,0,0,7B06300,Exploration of renal transplant,Feb-09,,,,,
27319,189,7,0,0,7800z00,Transplantation of liver NOS,Feb-09,,,,,
27679,10,1,0,0,SP08500,Heart-lung transplant failure and rejection,Feb-09,,,,,
29831,68,0,0,0,SP08000,Transplanted organ failure,Feb-09,,,,,
30052,70,0,0,0,SP...18,Transplant complications,Feb-09,,,,,1
31997,50,3,0,0,TB00200,"Liver transplant with complication, without blame",Feb-09,,,,,
32025,147,0,0,0,7800000,Orthotopic transplantation of liver,Feb-09,,,,,
35368,247,2,0,0,7830.00,Transplantation of pancreas,Feb-09,,,,,
37198,21,2,0,0,14S8.00,H/O: liver recipient,Feb-09,,,,,
38011,3,0,0,0,7450z00,Transplantation of lung NOS,Feb-09,,,,,
41495,25,0,0,0,7901z00,Other transplantation of heart NOS,Feb-09,,,,,
44077,87,0,0,0,ZV42y12,[V]Pancreas transplanted,Feb-09,,,,,
44893,51,0,0,0,SP08.00,Transplanted organ complication,Feb-09,,,,,
47033,10,0,0,0,ZLEQJ00,Discharge from transplant surgery service,Feb-09,,,,,1
47484,12,0,0,0,SP08400,Heart transplant failure and rejection,Feb-09,,,,,
48057,21,0,0,0,K0B5.00,Renal tubulo-interstitial disordrs in transplant rejectn,Feb-09,,,,,
48121,209,0,0,0,7B01500,Transplant nephrectomy,Feb-09,,,,,
49028,75,2,0,0,14S2.00,H/O: kidney recipient,Feb-09,,,,,
53626,2,0,0,0,7900000,Allotransplantation of heart and lung,Feb-09,,,,,
54990,49,2,0,0,TB00100,"Kidney transplant with complication, without blame",Feb-09,,,,,
55151,22,0,0,0,7B00000,Autotransplant of kidney,Feb-09,,,,,
56993,2,0,0,0,7830100,Transplantation of whole pancreas,Feb-09,,,,,
59394,16,0,0,0,14S3.00,H/O: heart recipient,Feb-09,,,,,
59610,54,0,0,0,8C31.00,Transplant immunosuppression,Feb-09,,,,,1
60955,16,1,0,0,7830300,Transplantation of islets of Langerhans,Feb-09,,,,,
61073,3,0,0,0,7900z00,Transplantation of heart and lung NOS,Feb-09,,,,,
64438,5,0,0,0,TB00000,"Heart transplant with complication, without blame",Feb-09,,,,,
65772,3,0,0,0,14S9.00,H/O: lung recipient,Feb-09,,,,,
66705,3,0,0,0,7B00111,Allotransplantation of kidney from live donor,Feb-09,,,,,
67499,13,0,0,0,7830z00,Transplantation of pancreas NOS,Feb-09,,,,,
69147,4,0,0,0,ZLD4K00,Discharge by transplant surgeon,Feb-09,,,,,1
69194,9,0,0,0,7800200,Replacement of previous liver transplant,Feb-09,,,,,
69734,3,0,0,0,7901y00,Other specified other transplantation of heart,Feb-09,,,,,
70712,5,0,0,0,SP08011,Det.ren.func.after ren.transpl,Feb-09,,,,,
70874,10,0,0,0,7B00y00,Other specified transplantation of kidney,Feb-09,,,,,
71422,4,0,0,0,7800100,Heterotopic transplantation of liver,Feb-09,,,,,
72004,4,0,0,0,7B01511,Excision of rejected transplanted kidney,Feb-09,,,,,
72939,2,0,0,0,7901100,Xenotransplantation of heart,Feb-09,,,,,
73743,2,0,0,0,7450y00,Other specified transplantation of lung,Feb-09,,,,,
89445,1,0,0,0,7800111,Auxillary liver transplant,Feb-09,,,,,
89924,9,0,0,0,7B00300,"Allotransplantation of kidney from cadaver, heart-beating",Feb-09,,,,,
90952,4,0,0,0,7B0F100,"Pre-transplantation of kidney work-up, recipient",Feb-09,,,,,
93366,5,0,0,0,7B0F.00,Interventions associated with transplantation of kidney,Feb-09,,,,,
93713,5,0,0,0,7450100,Single lung transplant,Feb-09,,,,,
93751,3,0,0,0,ZV42y11,[V]Intestine transplanted,Feb-09,,,,,
93844,2,0,0,0,7901500,Revision of transplantation of heart NEC,Feb-09,,,,,
94964,4,0,0,0,7B0F400,"Post-transplantation of kidney examination, live donor",Feb-09,,,,,
96095,21,1,0,0,7B0F200,"Pre-transplantation of kidney work-up, live donor",Feb-09,,,,,
96129,4,0,0,0,7831200,Excision of transplanted pancreas,Apr-09,,,,,
96133,8,0,0,0,7B00400,"Allotransplantation kidney from cadaver, heart non-beating",Apr-09,,,,,
96423,4,0,0,0,ZV42.11,[V]Transplanted organ,Apr-09,,,,,
96578,24,0,0,0,7450000,Double lung transplant,Apr-09,,,,,
97157,4,0,0,0,7800500,Orthotopic transplantation of liver NEC,Aug-09,,,,,
98364,2,0,0,0,7B00211,Allotransplantation of kidney from cadaver,Jan-10,,,,,
99250,1,0,0,0,7800y00,Other specified transplantation of liver,Apr-10,,,,,
99847,35,0,0,0,SP08A00,Post-transplant lymphoproliferative disorder,Jun-10,,,,,
100073,2,0,0,0,7800112,Piggy back liver transplant,Jul-10,,,,,
100621,3,0,0,0,764C.00,Transplantation of ileum,Sep-10,,,,,
100693,2,0,0,0,Kyu1C00,[X]Renal tubulo-interstitial disorders/transplant rejection,Sep-10,,,,,
101231,3,0,0,0,7830200,Transplantation of tail of pancreas,Dec-10,,,,,
102998,1,0,0,0,7125.00,Transplantation of thymus gland,Sep-11,,,,,
103429,2,0,0,0,7B0F300,"Post-transplantation of kidney examination, recipient",Dec-11,,,,,
103649,26,0,0,0,9b8K.00,Transplantation surgery,Jan-12,,,,,1
104049,3,0,0,0,7B0Fz00,Interventions associated with transplantation of kidney NOS,May-12,,,,,
104050,1,0,0,0,7B0Fy00,OS interventions associated with transplantation of kidney,May-12,,,,,
104201,13,0,0,0,SP08H00,Acute rejection of renal transplant,Jun-12,,,,,
104630,2,0,0,0,SP08G00,Acute rejection of renal transplant - grade III,Jul-12,,,,,
104905,1,0,0,0,SP08D00,Acute-on-chronic rejection of renal transplant,Sep-12,,,,,
104960,10,0,0,0,SP08E00,Acute rejection of renal transplant - grade I,Sep-12,,,,,
105328,60,0,0,0,7B00212,Cadaveric renal transplant,Dec-12,,,,,
105506,1,0,0,0,7800400,Orthotopic transplantation of whole liver,Dec-12,,,,,
105724,3,0,0,0,SP08N00,Unexplained episode of renal transplant dysfunction,Jan-13,,,,,
105787,3,0,0,0,7B00600,Xenograft renal transplant,Feb-13,,,,,
105811,17,0,0,0,SP08R00,Renal transplant rejection,Feb-13,,,,,
106015,0,0,0,0,7842000,Transplantation of spleen,May-13,,,,,
106301,1,0,0,0,SP08P00,Stenosis of vein of transplanted kidney,Jun-13,,,,,
106620,4,0,0,0,SP08J00,Chronic rejection of renal transplant,Aug-13,,,,,
106866,4,0,0,0,SP08W00,Vascular complication of renal transplant,Aug-13,,,,,
107000,1,0,0,0,SP08F00,Acute rejection of renal transplant - grade II,Sep-13,,,,,
107416,0,0,0,0,7901300,Piggyback transplantation of heart,Dec-13,,,,,
107752,2,0,0,0,SP08T00,Urological complication of renal transplant,Mar-14,,,,,
108330,1,0,0,0,SP08900,Complication of transplanted lung,Jul-14,,,,,
108437,1,0,0,0,SP08V00,Very mild acute rejection of renal transplant,Aug-14,,,,,
108705,1,0,0,0,SP08V11,Borderline changes of acute rejection,Oct-14,,,,,1
109304,1,0,0,0,9b8B200,Cardiothoracic transplantation,Feb-15,,,,,
109455,2,0,0,0,7B00500,Allotransplantation of kidney from cadaver NEC,Apr-15,,,,,
110789,2,0,0,0,761N.00,Transplantation of stomach,May-16,,,,,
111597,3,0,0,0,SP08B00,Post-transplant bronchiolitis obliterans syndrome,Jan-17,,,,,
10955,398,17,0,0,C391100,Di George syndrome,Feb-09,,,,,
16903,4,0,0,0,F14y011,Louis - Bar syndrome,Feb-09,,,,,
31322,41,5,0,0,C391200,Wiskott - Aldrich syndrome,Feb-09,,,,,
31541,16,3,0,0,C392300,Severe combined immunodefiency with reticular dysgenesis,Feb-09,,,,,
39800,67,5,0,0,C39X.00,"Immunodeficiency associated+major defect, unspecified",Feb-09,,,,,
42439,23,1,0,0,C391211,Thrombocytopenic eczema with immunodeficiency,Feb-09,,,,,
48293,14,0,0,0,C392100,Severe combined immunodeficiency,Feb-09,,,,,
49530,68,3,3,0,BBmC.00,[M] T-gamma lymphoproliferative disease,Feb-09,,,,,
49542,6,0,0,0,C392500,Severe combined immunodef with low or normal B-cell numbers,Feb-09,,,,,
50526,12,0,0,0,C392800,Major histocompatibility complex class I deficiency,Feb-09,,,,,
54904,7,0,0,0,C39y000,Lymphocyte function antigen-1 defect,Feb-09,,,,,
56108,18,2,2,0,C396.00,Immunodef follow hereditary defect respon Epstein-Barr vir,Feb-09,,,,,
57552,10,0,0,0,C30yy11,Adenosine-deaminase deficiency,Feb-09,,,,,
57809,2,0,0,0,D401111,FEL-Familial erythrophagocytic lymph histiocytosis,Feb-09,,,,,
61326,2,0,0,0,D201612,Pancytopenia with pancreatitis,Feb-09,,,,,
62236,8,0,0,0,C392.00,Combined immunity deficiency,Feb-09,,,,,
62328,3,0,0,0,C392z00,Combined immunity deficiency NOS,Feb-09,,,,,
65617,4,0,0,0,C395.00,Immunodeficiency with short-limbed stature,Feb-09,,,,,
66073,13,0,0,0,C392400,Severe combined immunodef with low T- and B-cell numbers,Feb-09,,,,,
72804,3,0,0,0,C392600,Adenosine deaminase deficiency,Feb-09,,,,,
73583,24,0,0,0,F14y000,Ataxia-telangiectasia,Feb-09,,,,,
93936,4,0,0,0,C392700,Purine nucleoside phosphorylase deficiency,Feb-09,,,,,
103977,1,0,0,0,C392900,Major histocompatibility complex class II deficiency,May-12,,,,,